Kentucky
(State
or other jurisdiction
of
incorporation or organization)
|
20-0865835
(I.R.S.
Employer Identification No.)
|
Title
of each class
|
Name
of each exchange on which registered
|
||
Common
Stock, par value $.01 per share
|
New
York Stock Exchange
|
Page | ||||
PART
I
|
||||
Item
1.
|
Business
...................................................................................................................................................................
|
1
|
||
General
....................................................................................................................................................................
|
1
|
|||
Ashland Aqualon Functional Ingredients ......................................................................................................... | 2 | |||
Ashland Hercules Water Technologies ............................................................................................................. | 2 | |||
Ashland Performance Materials .......................................................................................................................... | 3 | |||
Ashland Consumer Markets ................................................................................................................................ | 4 | |||
Ashland Distribution
...........................................................................................................................................
|
5
|
|||
Miscellaneous
.......................................................................................................................................................
|
6
|
|||
Item
1A.
|
Risk
Factors
.............................................................................................................................................................
|
8
|
||
Item
1B.
|
Unresolved
Staff Comments
.................................................................................................................................
|
11
|
||
Item
2.
|
Properties
.................................................................................................................................................................
|
11
|
||
Item
3.
|
Legal
Proceedings
..................................................................................................................................................
|
12
|
||
Item
4.
|
Submission
of Matters to a Vote of Security Holders
......................................................................................
|
13
|
||
Item
X.
|
Executive
Officers of Ashland
..............................................................................................................................
|
13
|
||
PART
II
|
||||
Item
5.
|
Market
for Registrant’s Common Equity, Related Stockholder
Matters and Issuer Purchases of
Equity Securities
........................................................................................
|
14
|
||
Performance
Graph
...............................................................................................................................................
|
15
|
|||
Item
6.
|
Selected Financial Data
.........................................................................................................................................
|
16
|
||
Item
7.
|
Management’s
Discussion and Analysis of Financial
Condition and Results of
Operations
................................................................................................................
|
16
|
||
Item
7A
|
Quantitative
and Qualitative Disclosures about Market Risk
..........................................................................
|
16
|
||
Item
8.
|
Financial
Statements and Supplementary Data
..................................................................................................
|
16
|
||
Item
9.
|
Changes
in and Disagreements with Accountants
on Accounting and Financial
Disclosure
.........................................................................................................
|
16
|
||
Item
9A.
|
Controls
and Procedures
.......................................................................................................................................
|
16
|
||
Item
9B.
|
Other
Information ....................................................................................................................................................
|
16
|
||
PART
III
|
||||
Item
10.
|
Directors,
Executive Officers and Corporate Governance
................................................................................
|
17
|
||
Item
11.
|
Executive
Compensation
........................................................................................................................................
|
17
|
||
Item
12.
|
Security
Ownership of Certain Beneficial Owners
and Management and Related
Stockholder Matters
.......................................................................................
|
17
|
||
Item
13.
|
Certain
Relationships and Related Transactions, and Director
Independence
........................................................................................................................................................
|
18
|
||
Item
14.
|
Principal
Accountant Fees and Services
.............................................................................................................
|
18
|
||
PART
IV
|
||||
Item
15.
|
Exhibits
and Financial Statement Schedules
.......................................................................................................
|
18
|
|
§
|
limiting
Ashland’s ability to borrow additional amounts to fund working capital,
capital expenditures, acquisitions, debt service requirements, execution
of its growth strategy and other
purposes;
|
|
§
|
requiring
Ashland to dedicate a substantial portion of its cash flow from operations
to pay interest on its debt, which would reduce availability of Ashland’s
cash flow to fund working capital, capital expenditures, acquisitions,
execution of its growth strategy and other general corporate
purposes;
|
|
§
|
making
Ashland more vulnerable to adverse changes in general economic, industry
and government regulations and in its business by limiting its flexibility
in planning for, and making it more difficult for Ashland to react quickly
to, changing conditions;
|
|
§
|
placing
Ashland at a competitive disadvantage compared with those of its
competitors that have less debt;
and
|
|
§
|
exposing
Ashland to risks inherent in interest rate fluctuations because some of
its borrowings will be at variable rates of interest, which could result
in higher interest expense in the event of increases in interest
rates.
|
|
§
|
provisions
relating to the classification, nomination and removal of its
directors;
|
|
§
|
provisions
limiting the right of shareholders to call special meetings of its Board
of Directors and shareholders;
|
|
§
|
provisions
regulating the ability of its shareholders to bring matters for action at
annual meetings of its shareholders;
and
|
|
§
|
an
authorization to its Board of Directors to issue and set the terms of
preferred stock.
|
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
|
Ashland
1
|
100
|
122
|
143
|
157
|
78
|
118
|
S&P
500
|
100
|
112
|
124
|
145
|
113
|
105
|
S&P
400 Midcap
|
100
|
122
|
130
|
154
|
129
|
125
|
Peer Group 2
|
100
|
171
|
183
|
229
|
211
|
239
|
1
|
Ashland’s
former Petroleum Refining and Marketing operations consisted primarily of
its 38% interest in Marathon Ashland Petroleum LLC which was transferred
on June 30, 2005, along with two other businesses, to Marathon Oil
Corporation. Ashland’s former Transportation Construction
operations consisted of Ashland Paving And Construction, Inc. which was
sold on August 28, 2006, to Oldcastle Materials,
Inc.
|
2
|
Ashland’s
Peer Group five-year cumulative total return index reflects Petroleum
Refining and Marketing peers for fiscal 2005 and Transportation and
Construction peers for fiscal 2005
and 2006.
|
|
∙
|
Specialty Chemical Production,
Distribution, and Motor Oil and Car Care Products
Portfolio: Standard & Poor’s 500 Specialty Chemicals
(Large-Cap), Standard & Poor’s 400 Specialty Chemicals (Mid-Cap),
Standard & Poor’s 600 Specialty Chemicals (Small-Cap), and Standard
& Poor’s 400 Diversified Chemicals
(Mid-Cap).
|
|
∙
|
Highway Construction
Portfolio, for fiscal 2005 and 2006 only: Standard &
Poor’s 500 Construction Materials (Large-Cap), Standard & Poor’s 400
Construction Materials (Mid-Cap), and Standard & Poor’s 600
Construction Materials (Small-Cap).
|
|
∙
|
Petroleum Refining and
Marketing Portfolio, for fiscal 2005 only: Standard
& Poor’s 500 Oil & Gas Refining & Marketing &
Transportation (Large-Cap), Standard & Poor’s 400 Oil & Gas
Refining & Marketing & Transportation (Mid-Cap), and Standard
& Poor’s 600 Oil & Gas Refining & Marketing &
Transportation (Small-Cap).
|
Equity
Compensation Plan Information
|
||||||||||||
Plan
Category
|
Number
of securities
to
be issued upon
exercise
of
outstanding options,
warrants
and rights
|
Weighted-average
exercise
price of
outstanding
options,
warrants
and rights
|
Number
of securities
remaining
available for
future
issuance under
equity
compensation plans
(excluding
securities
reflected
in column (a))
|
|||||||||
(a)
|
(b)
|
(c)
|
Equity
compensation plans
approved by
security holders
|
2,541,657 | (1) | $ | 17.14 | (2) | 1,559,342 | (3) | |||||
Equity
compensation plans
not
approved by security
holders
|
110,944 | (4) | 880,041 | (5) |
Total
|
2,652,601 | $ | 17.14 | (2) | 2,439,383 |
(1)
|
This
figure includes (a) 37,542 stock options outstanding under the Ashland
Inc. 1997 Stock Incentive Plan, (b) 473,642 stock options outstanding
under the Amended and Restated Ashland Inc. Incentive Plan (the “Amended
Plan”), (c) 108,366 stock options outstanding under the Hercules
Incorporated Amended and Restated Long Term Incentive Compensation Plan,
and (d) 32,406 stock options outstanding under the Hercules Incorporated
Omnibus Equity Compensation Plan for Non-Employee
Directors. This figure also includes 59,538 net shares that
could be issued under stock-settled SARs under the Amended Plan and
985,656 net shares that could be issued under stock-settled SARs under the
2006 Ashland Inc. Incentive Plan (the “2006 Plan”), based upon the closing
price of Ashland Common Stock on the New York Stock Exchange Composite
Tape on September 30, 2009 ($43.22). Additionally, this figure
includes
|
|
251,943
restricted stock shares granted under the Amended Plan and deferred,
114,065 performance share units for the 2007-2009 performance period,
102,268 performance share units for the 2008-2010 performance period and
276,058 performance share units for the 2009-2011 performance period,
payable in stock under the 2006 Plan, estimated assuming target
performance is achieved. Also included in the figure are 100,173 shares to
be issued under the pre-2005 Deferred Compensation Plan for Employees,
payable in stock upon termination of employment with
Ashland.
|
(2)
|
The
weighted-average exercise price excludes shares in Ashland Common Stock
which may be distributed under the deferred compensation plans and the
deferred restricted stock and performance share units which may be
distributed under the Amended Plan and 2006 Plan as described in footnotes
(1) and (4) in this table.
|
(3)
|
This
figure includes 1,072,890 shares available for issuance under the 2006
Plan, 149,152 shares available for issuance under the pre-2005 Deferred
Compensation Plan for Employees and 337,300 shares available for issuance
under the pre-2005 Deferred Compensation Plan for Non-Employee
Directors.
|
(4)
|
This
figure includes 88,926 shares to be issued under the Deferred Compensation
Plan for Employees (2005) and 22,018 shares to be issued under the
Deferred Compensation Plan for Non-Employee Directors (2005), payable in
stock upon termination of employment or service with Ashland. Because
these plans are not equity compensation plans as defined by the rules of
the New York Stock Exchange (“NYSE”), neither plan required approval by
Ashland’s shareholders.
|
(5)
|
This
figure includes 403,599 shares available for issuance under the Deferred
Compensation Plan for Employees (2005) and 476,442 shares available for
issuance under the Deferred Compensation Plan for Non-Employee Directors
(2005). Because these plans are not equity compensation plans
as defined by the rules of the NYSE, neither plan required approval by
Ashland’s shareholders.
|
|
3.1
|
-
|
Third
Restated Articles of Incorporation of Ashland and amendment thereto
effective February 3, 2009 (filed as Exhibit 3.1 to Ashland’s Form 10-Q
for the quarter ended December 31, 2008, and incorporated herein by
reference).
|
|
3.2
|
-
|
By-laws
of Ashland, effective as of June 30, 2005 (filed as Exhibit 3(ii) to
Ashland’s Form 10-Q for the quarter ended June 30, 2005, and incorporated
herein by reference).
|
|
4.1
|
-
|
Ashland
agrees to provide the SEC, upon request, copies of instruments defining
the rights of holders of long-term debt of Ashland and all of its
subsidiaries for which consolidated or unconsolidated financial statements
are required to be filed with the
SEC.
|
|
4.2
|
-
|
Indenture,
dated as of August 15, 1989, as amended and restated as of August 15,
1990, between Ashland and Citibank, N.A., as Trustee (filed as Exhibit 4.2
to Ashland’s Form 10-K for the fiscal year ended September 30, 2008, and
incorporated herein by reference).
|
|
4.3
|
-
|
Agreement
of Resignation, Appointment and Acceptance, dated as of November 30, 2006,
by and among Ashland, Wilmington Trust Company (“Wilmington”) and
Citibank, N.A. (“Citibank”) whereby Wilmington replaced Citibank as
Trustee under the Indenture dated as of August 15, 1989, as amended and
restated as of August 15, 1990, between Ashland and Citibank (filed as
Exhibit 4 to Ashland’s Form 10-Q for the quarter ended December 31, 2006,
and incorporated herein by
reference).
|
|
4.4
|
-
|
Indenture,
dated May 27, 2009, by and among Ashland, the Guarantors and U.S. Bank
National Association (filed as Exhibit 4.1 to Ashland’s Form 10-Q for the
quarter ended June 30, 2009, and incorporated herein by
reference).
|
|
4.5
|
-
|
Registration
Rights Agreement, dated May 27, 2009, by and among Ashland, the Guarantors
and Banc of America Securities, LLC and Scotia Capital (USA) Inc. (filed
as Exhibit 4.2 to Ashland’s Form 10-Q for the quarter ended June 30, 2009,
and incorporated herein by
reference).
|
|
4.6
|
-
|
Warrant
Agreement dated July 27, 1999 between Hercules and The Chase Manhattan
Bank, as warrant agent (filed as Exhibit 4.4 to Hercules’ Form
8-K filed on July 28, 1999 (SEC File No. 001-00496), and incorporated
herein by reference).
|
|
4.7
|
-
|
Form
of Series A Junior Subordinated Deferrable Interest Debentures (filed as
Exhibit 4.5 to Hercules’ Form 8-K filed on July 28, 1999 (SEC File No.
001-00496), and incorporated herein by
reference).
|
|
4.8
|
-
|
Form of CRESTSSM
Unit (filed as Exhibit 4.7
to Hercules’ Form 8-K filed on July 28, 1999 (SEC File No. 001-00496), and
incorporated herein by
reference).
|
|
4.9
|
-
|
Form
of Warrant (filed as Exhibit 4.8 to Hercules’ Form 8-K filed on July 28,
1999 (SEC File No. 001-00496), and incorporated herein by
reference).
|
|
4.10
|
-
|
Registration
Rights Agreement dated as of November 3, 2009 between Ashland Inc. and
Evercore Trust Company, N.A. (filed as Exhibit 4.1 to Ashland’s Form 8-K
filed on November 6, 2009, and incorporated herein by
reference).
|
|
10.1
|
-
|
Ashland
Inc. Deferred Compensation Plan for Non-Employee Directors and Amendment
No. 1 (filed as Exhibit 10.5 to Ashland’s Form 10-Q for the quarter ended
December 31, 2004, and incorporated herein by
reference).
|
|
10.2
|
-
|
Ashland
Inc. Deferred Compensation Plan and Amendment No. 1 (filed as Exhibit 10.3
to Ashland’s Form 10-Q for the quarter ended December 31, 2004, and
incorporated herein by reference).
|
|
10.3
|
-
|
Amended
and Restated Ashland Inc. Deferred Compensation Plan for Employees (2005)
(filed as Exhibit 10.3 to Ashland’s Form 10-K for the fiscal year ended
September 30, 2008, and incorporated herein by
reference).
|
|
10.4
|
-
|
Amended
and Restated Ashland Inc. Deferred Compensation Plan for Non-Employee
Directors (2005) (filed as Exhibit 10.4 to Ashland’s Form 10-K for the
fiscal year ended September 30, 2008, and incorporated herein by
reference).
|
|
10.5
|
-
|
Amended
and Restated Ashland Inc. Supplemental Early Retirement Plan for Certain
Employees (filed as Exhibit 10.5 to Ashland’s Form 10-K for the fiscal
year ended September 30, 2008, and incorporated herein by
reference).
|
|
10.6
|
-
|
Amendment
No. 1 to Amended and Restated Ashland Inc. Supplemental Early Retirement
Plan for Certain Employees (filed as Exhibit 10.1 to Ashland’s Form 10-Q
for the quarter ended December 31, 2008, and incorporated herein by
reference).
|
|
10.7
|
-
|
Amended
and Restated Ashland Inc. Nonqualified Excess Benefit Pension Plan (filed
as Exhibit 10.6 to Ashland’s Form 10-K for the fiscal year ended September
30, 2008, and incorporated herein by
reference).
|
|
10.8
|
-
|
Hercules
Incorporated Long Term Incentive Compensation Plan (as Amended and
Restated) (filed as Exhibit 10.2 to Ashland’s Form 10-Q for the quarter
ended December 31, 2008, and incorporated herein by
reference).
|
|
10.9
|
-
|
Form
of Chief Executive Officer Change in Control Agreement (filed as Exhibit
10.1 to Ashland’s Form 8-K filed on January 7, 2009, and incorporated
herein by reference).
|
|
10.10
|
-
|
Form
of Executive Officer Change in Control Agreement (filed as Exhibit 10.2 to
Ashland’s Form 8-K filed on January 7, 2009, and incorporated herein by
reference).
|
|
10.11
|
-
|
Form
of Executive Officer Change in Control Agreement, effective for agreements
entered into after July 2009.
|
|
10.12
|
-
|
Ashland
Inc. Severance Pay Plan (filed as Exhibit 10.3 to Ashland’s Form 8-K filed
on January 7, 2009, and incorporated herein by
reference).
|
|
10.13
|
-
|
Employment
Agreement between Ashland and John E. Panichella (filed as Exhibit 10.14
to Ashland’s Form 10-K for the fiscal year ended September 30, 2008, and
incorporated herein by reference).
|
|
10.14
|
-
|
Employment
Agreement between Ashland and Paul C. Raymond, III (filed as Exhibit 10.15
to Ashland’s Form 10-K for the fiscal year ended September 30, 2008, and
incorporated herein by reference).
|
|
10.15
|
-
|
Form
of Indemnification Agreement between Ashland and members of its Board of
Directors (filed as Exhibit 10.10 to Ashland’s annual report on Form 10-K
for fiscal year ended September 30, 2005, and incorporated herein by
reference).
|
|
10.16
|
-
|
Ashland
Inc. 1997 Stock Incentive Plan (filed as Exhibit 10.17 to Ashland’s Form
10-K for the fiscal year ended September 30, 2008, and incorporated herein
by reference).
|
|
10.17
|
-
|
Amended
and Restated Ashland Inc. Incentive
Plan.
|
|
10.18
|
-
|
2006
Ashland Inc. Incentive Plan (filed as Exhibit 10 to Ashland’s Form 10-Q
for the quarter ended December 31, 2005, and incorporated herein by
reference).
|
|
10.19
|
-
|
Form
of Notice granting Stock Appreciation Rights
Awards.
|
|
10.20
|
-
|
Form
of Notice granting Restricted Stock Awards (filed as Exhibit 10.21 to
Ashland’s Form 10-K for the fiscal year ended September 30, 2008, and
incorporated herein by reference).
|
|
10.21
|
-
|
Agreement
and Plan of Merger dated as of July 10, 2008 among Ashland, Ashland
Sub-One, Inc. and Hercules Incorporated (filed as Exhibit 2.1 to Ashland’s
Form 8-K filed on July 14, 2008, and incorporated herein by
reference).
|
|
10.22
|
-
|
Credit
Agreement dated as of November 13, 2008 among Ashland, Bank of America,
N.A., as Administrative Agent, The Bank of Nova Scotia, as Syndication
Agent, the other Lenders party thereto, and Banc of America Securities LLC
and The Bank of Nova Scotia, as Joint Lead Arrangers and Joint Book
Managers (filed as Exhibit 10.1 to Ashland’s Form 8-K filed on November
19, 2008, and incorporated herein by
reference).
|
|
10.23
|
-
|
Amendment
No. 1 to Credit Agreement, dated as of April 17, 2009 (filed as Exhibit 10
to Ashland’s Form 10-Q for the quarter ended March 31, 2009, and
incorporated herein by reference).
|
|
10.24
|
-
|
Amendment
No. 2 to Credit Agreement, dated as of May 20, 2009 (filed as Exhibit 10.2
to Ashland’s Form 10-Q for the quarter ended June 30, 2009, and
incorporated herein by reference).
|
|
10.25
|
-
|
Transfer
and Administration Agreement dated as of November 13, 2008 among CVG
Capital II LLC, Ashland, in its capacity as both initial Originator and
initial Servicer, each of YC SUSI Trust and Liberty Street Funding LLC, as
Conduit Investors and Uncommitted Investors, Bank of America, National
Association, as a Letter of Credit Issuer, a Managing Agent, an
Administrator and a Committed Investor and as the Agent, The Bank of Nova
Scotia, as a Letter of Credit Issuer, a Managing Agent, an Administrator
and a Committed Investor, and the Letter of Credit Issuers, Managing
Agents, Administrators, Uncommitted Investors and Committed Investors
parties thereto from time to time (filed as Exhibit 10.3 to Ashland’s Form
8-K filed on November 19, 2008, and incorporated herein by
reference).
|
|
10.26
|
-
|
First
Amendment to the Transfer and Administration Agreement dated as of
November 4, 2009 among Ashland Inc., CVG Capital II LLC, the Investors,
Letter of Credit Issuers, Managing Agents and Administrators party hereto,
and Bank of America, N.A., as Agent for the
Investors.
|
|
10.27
|
-
|
Sale
Agreement dated as of November 13, 2008 among Ashland and CVG Capital II
LLC (filed as Exhibit 10.4 to Ashland’s Form 8-K filed on November 19,
2008, and incorporated herein by
reference).
|
|
10.28
|
-
|
Purchase
Agreement for the $650 Million 9 1/8% Senior Notes due 2017, dated May 19,
2009, between Ashland and Banc of America Securities, LLC, Scotia Capital
(USA) Inc. and SunTrust Robinson Humphrey, Inc. (filed as Exhibit 10.1 to
Ashland’s Form 10-Q for the quarter ended June 30, 2009, and incorporated
herein by reference).
|
|
11
|
-
|
Computation
of Earnings Per Share (appearing in Note A of “Notes to Consolidated
Financial Statements” in this annual report on Form
10-K).
|
|
12
|
-
|
Computation
of Ratio of Earnings to Fixed
Charges.
|
|
21
|
-
|
List
of Subsidiaries.
|
|
23.1
|
-
|
Consent
of PricewaterhouseCoopers LLP.
|
|
23.2
|
-
|
Consent
of Ernst & Young LLP.
|
|
23.3
|
-
|
Consent
of Hamilton, Rabinovitz & Associates,
Inc..
|
|
24
|
-
|
Power
of Attorney.
|
|
31.1
|
-
|
Certification
of James J. O’Brien, Chief Executive Officer of Ashland, pursuant to
Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
31.2
|
-
|
Certification
of Lamar M. Chambers, Chief Financial Officer of Ashland, pursuant to
Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
32
|
-
|
Certification
of James J. O’Brien, Chief Executive Officer of Ashland, and Lamar M.
Chambers, Chief Financial Officer of Ashland, pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
|
ASHLAND
INC.
|
|||
(Registrant)
|
|||
By:
|
|||
/s/
Lamar M. Chambers
|
|||
Lamar
M. Chambers
|
|||
Senior
Vice President and Chief Financial Officer
|
|||
Date:
November 23, 2009
|
Signatures
|
Capacity
|
||
/s/
James J. O'Brien
_____________________________________
James
J. O’Brien
|
Chairman
of the Board, Chief Executive Officer and Director
(Principal
Executive Officer)
|
||
/s/
Lamar M. Chambers
_____________________________________
Lamar
M. Chambers
|
Senior
Vice President and Chief Financial Officer
(Principal
Financial Officer)
|
||
/s/
J. William Heitman
_____________________________________
J.
William Heitman
|
Vice
President and Controller
(Principal Accounting Officer)
|
||
*
_____________________________________
Roger
W. Hale
|
Director
|
||
*
_____________________________________
Bernadine
P. Healy
|
Director
|
||
*
_____________________________________
Kathleen
Ligocki
|
Director
|
||
*
_____________________________________
Vada
O. Manager
|
Director
|
||
*
_____________________________________
Barry
W. Perry
|
Director
|
||
*
_____________________________________
Mark
C. Rohr
|
Director
|
||
*
_____________________________________
George
A. Schaefer, Jr.
|
Director
|
||
*
_____________________________________
Theodore
M. Solso
|
Director
|
||
*
_____________________________________
John
F. Turner
|
Director
|
||
*
_____________________________________
Michael
J. Ward
|
Director
|
*By:
|
/s/
David L. Hausrath
|
David
L. Hausrath
|
Attorney-in-Fact
|
|
Date: | November 23, 2009 |
Revenues
by Geography
|
2009
|
(a) |
2008
|
2007
|
||||||||
North
America
|
68 | % | 71 | % | 72 | % | ||||||
Europe
|
20 | % | 21 | % | 20 | % | ||||||
Asia
Pacific
|
8 | % | 5 | % | 5 | % | ||||||
Latin
America & other
|
4 | % | 3 | % | 3 | % | ||||||
100 | % | 100 | % | 100 | % | |||||||
|
2009
|
(a) |
2008
|
2007
|
||||||||
Functional
Ingredients
|
10%
|
n/a
|
n/a
|
|||||||||
Water
Technologies
|
20%
|
11%
|
11%
|
|||||||||
Performance
Materials
|
13%
|
19%
|
18%
|
|||||||||
Consumer
Markets
|
20%
|
19%
|
20%
|
|||||||||
Distribution
|
37%
|
51%
|
51%
|
|||||||||
100%
|
100%
|
100%
|
||||||||||
·
|
Freezing
wage and salaries globally for 2009, except where legally mandated
otherwise, with estimated savings of approximately $25 million;
and
|
·
|
Implementing
a two-week furlough program for most U.S. and Canadian based employees,
that was essentially completed in June of 2009, and several other job and
benefits related actions. Furlough program savings totaled
approximately $25 million.
|
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
|
2008
change
|
||||||||||||||
Sales
and operating revenues
|
$ | 8,106 | $ | 8,381 | $ | 7,785 | $ | (275 | ) | $ | 596 |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Cost
of sales and operating expenses
|
$ | 6,317 | $ | 7,056 | $ | 6,447 | $ | (739 | ) | $ | 609 | |||||||||
Gross
profit as a percent of sales
|
22.1 | % | 15.8 | % | 17.2 | % |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Selling, general
and administrative expenses
|
$ | 1,341 | $ | 1,118 | $ | 1,126 | $ | 223 | $ | (8 | ) | |||||||||
As
a percent of revenues
|
16.5 | % | 13.3 | % | 14.5 | % |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Research
and development expenses
|
$ | 96 | $ | 48 | $ | 45 | $ | 48 | $ | 3 |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Equity
and other income
|
||||||||||||||||||||
Equity
income
|
$ | 14 | $ | 23 | $ | 15 | $ | (9 | ) | $ | 8 | |||||||||
Other
income
|
24 | 31 | 34 | (7 | ) | (3 | ) | |||||||||||||
$ | 38 | $ | 54 | $ | 49 | $ | (16 | ) | $ | 5 |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Net
gain (loss) on divestitures
|
$ | 59 | $ | 20 | $ | (3 | ) | $ | 39 | $ | 23 |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Net
interest and other financing (expense) income
|
||||||||||||||||||||
Interest
income
|
$ | 21 | $ | 40 | $ | 59 | $ | (19 | ) | $ | (19 | ) | ||||||||
Interest
expense
|
(215 | ) | (9 | ) | (10 | ) | (206 | ) | 1 | |||||||||||
Other
financing costs
|
(11 | ) | (3 | ) | (3 | ) | (8 | ) | - | |||||||||||
$ | (205 | ) | $ | 28 | $ | 46 | $ | (233 | ) | $ | (18 | ) |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Other
expenses
|
||||||||||||||||||||
Loss
on currency swaps
|
$ | (54 | ) | $ | - | $ | - | $ | (54 | ) | $ | - | ||||||||
Loss
on auction rate securities
|
(32 | ) | - | - | (32 | ) | - | |||||||||||||
$ | (86 | ) | $ | - | $ | - | $ | (86 | ) | $ | - |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Income
tax expense
|
$ | 80 | $ | 86 | $ | 58 | $ | (6 | ) | $ | 28 | |||||||||
Effective
tax rate
|
50.6 | % | 32.9 | % | 22.3 | % |
(In
millions)
|
2009
|
2008
|
2007
|
2009
change
|
2008
change
|
|||||||||||||||
Income
from discontinued operations (net of tax)
|
||||||||||||||||||||
APAC
|
$ | (6 | ) | $ | (6 | ) | $ | (5 | ) | $ | - | $ | (1 | ) | ||||||
Asbestos-related
litigation reserves
|
2 | (2 | ) | 35 | 4 | (37 | ) | |||||||||||||
Electronic
Chemicals
|
(3 | ) | - | (1 | ) | (3 | ) | 1 | ||||||||||||
$ | (7 | ) | $ | (8 | ) | $ | 29 | $ | 1 | $ | (37 | ) |
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
December
31
|
$ | (7 | ) | $ | 46 | $ | 58 | |||||
March
31
|
112 | 52 | 41 | |||||||||
June
30
|
152 | 87 | 91 | |||||||||
September
30
|
133 | 28 | 26 |
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Sales
and operating revenues
|
||||||||||||
Functional
Ingredients
|
$ | 812 | $ | - | $ | - | ||||||
Water
Technologies
|
1,652 | 893 | 818 | |||||||||
Performance
Materials
|
1,106 | 1,621 | 1,580 | |||||||||
Consumer
Markets
|
1,650 | 1,662 | 1,525 | |||||||||
Distribution
|
3,020 | 4,374 | 4,031 | |||||||||
Intersegment
sales
|
(134 | ) | (169 | ) | (169 | ) | ||||||
$ | 8,106 | $ | 8,381 | $ | 7,785 | |||||||
Operating
income (loss)
|
||||||||||||
Functional
Ingredients
|
$ | 36 | $ | - | $ | - | ||||||
Water
Technologies
|
78 | 10 | 16 | |||||||||
Performance
Materials
|
1 | 52 | 89 | |||||||||
Consumer
Markets
|
252 | 83 | 86 | |||||||||
Distribution
|
52 | 51 | 41 | |||||||||
Unallocated
and other
|
(29 | ) | 17 | (16 | ) | |||||||
$ | 390 | $ | 213 | $ | 216 | |||||||
Depreciation
and amortization
|
||||||||||||
Functional
Ingredients (a)
|
$ | 106 | $ | - | $ | - | ||||||
Water
Technologies (a)
|
99 | 29 | 29 | |||||||||
Performance
Materials
|
63 | 46 | 39 | |||||||||
Consumer
Markets
|
36 | 35 | 34 | |||||||||
Distribution
|
28 | 28 | 25 | |||||||||
Unallocated
and other
|
7 | 7 | 6 | |||||||||
$ | 339 | $ | 145 | $ | 133 |
Operating
information
|
||||||||||||
Functional
Ingredients (b)
(c)
|
||||||||||||
Sales
per shipping day
|
$ | 3.7 | $ | - | $ | - | ||||||
Metric
tons sold (thousands)
|
154.1 | - | - | |||||||||
Gross profit as a percent of sales | 26.7 | % | - | - | ||||||||
Water
Technologies (b)
(c)
|
||||||||||||
Sales
per shipping day
|
$ | 6.6 | $ | 3.5 | $ | 3.1 | ||||||
Gross profit as a percent of sales | 33.9 | % | 36.7 | % | 39.2 | % | ||||||
Performance
Materials (b)
|
||||||||||||
Sales
per shipping day
|
$ | 4.4 | $ | 6.4 | $ | 6.1 | ||||||
Pounds
sold per shipping day
|
3.9 | 4.9 | 4.9 | |||||||||
Gross profit as a percent of sales | 17.0 | % | 17.0 | % | 20.5 | % | ||||||
Consumer
Markets (b)
|
||||||||||||
Lubricant
sales gallons
|
158.8 | 169.2 | 167.1 | |||||||||
Premium lubricants (percent of U.S. branded volumes) | 28.2 | % | 24.9 | % | 23.3 | % | ||||||
Gross profit as a percent of sales | 32.0 | % | 23.0 | % | 24.8 | % | ||||||
Distribution
(b)
|
||||||||||||
Sales
per shipping day
|
$ | 12.0 | $ | 17.3 | $ | 15.9 | ||||||
Pounds
sold per shipping day
|
14.7 | 18.8 | 19.6 | |||||||||
Gross profit as a percent of sales (d) | 10.0 | % | 7.8 | % | 7.9 | % | ||||||
(a)
|
Includes,
during 2009, amortization for purchased in-process research and
development of $5 million within both Functional Ingredients and Water
Technologies.
|
(b)
|
Sales
are defined as sales and operating revenues. Gross profit is
defined as sales and operating revenues, less cost of sales and operating
expenses.
|
(c)
|
Industry
segment results from November 14, 2008 forward include operations acquired
from Hercules Incorporated.
|
(d)
|
Distribution’s
gross profit as a percentage of sales for 2009 and 2008 include a LIFO
quantity credit of $15 million and $16 million,
respectively. There was no LIFO quantity credit for
2007.
|
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Cash
(used) provided by:
|
||||||||||||
Operating
activities from continuing operations
|
$ | 1,027 | $ | 478 | $ | 189 | ||||||
Investing
activities from continuing operations
|
(2,115 | ) | (418 | ) | (6 | ) | ||||||
Financing
activities from continuing operations
|
573 | (70 | ) | (1,016 | ) | |||||||
Discontinued
operations
|
(2 | ) | (8 | ) | (95 | ) | ||||||
Effect
of currency exchange rate changes on cash and cash
equivalents
|
(17 | ) | 7 | 5 | ||||||||
Net
decrease in cash and cash equivalents
|
$ | (534 | ) | $ | (11 | ) | $ | (923 | ) |
September
30
|
September
30
|
|||||||
(In
millions)
|
2009
|
2008
|
||||||
Short-term
debt
|
$ | 23 | $ | - | ||||
Long-term
debt (including current portion)
|
1,590 | 66 | ||||||
Total
debt
|
$ | 1,613 | $ | 66 | ||||
Cash
and cash equivalents
|
$ | 352 | $ | 886 | ||||
Auction
rate securities
|
$ | 170 | $ | 243 |
Maximum
consolidated
leverage
ratio
|
||||||||||||||
For
fiscal quarters ending:
|
||||||||||||||
Funding
date through September 30, 2009
|
3.75:1.00
|
|||||||||||||
December
31, 2009 through September 30, 2010
|
3.50:1.00
|
|||||||||||||
December
31, 2010 through September 30, 2011
|
3.00:1.00
|
|||||||||||||
December
31, 2011 through September 30, 2012
|
2.75:1.00
|
|||||||||||||
December
31, 2012 and each fiscal quarter thereafter
|
2.50:1.00
|
|
Covenant
|
|||||||||||||||||||||||
(In
millions, except ratios) (a)
|
Q1'09
|
Q2'09
|
Q3'09
|
Q4'09
|
Total
|
ratio
|
||||||||||||||||||
Debt/EBITDA
|
||||||||||||||||||||||||
Consolidated
EBITDA
|
$ | 155 | $ | 227 | $ | 266 | $ | 304 | $ | 952 | ||||||||||||||
Debt
|
2,473 | 2,266 | 2,021 | 1,642 | 1,642 | |||||||||||||||||||
Debt/EBITDA
|
1.7 | x | 3.75 | x | ||||||||||||||||||||
max.
|
||||||||||||||||||||||||
Reconciliation
of Consolidated EBITDA:
|
||||||||||||||||||||||||
(In
millions)
|
Q1'09
|
Q2'09
|
Q3'09
|
Q4'09
|
||||||||||||||||||||
Net
(loss) income
|
$ | (119 | ) | $ | 48 | $ | 50 | $ | 93 | |||||||||||||||
Key
items excluded (b)
|
82 | (1 | ) | 3 | - | |||||||||||||||||||
Consolidated
interest charges
|
35 | 56 | 64 | 63 | ||||||||||||||||||||
Income
taxes (benefit) expense
|
(1 | ) | 9 | 40 | 39 | |||||||||||||||||||
Depreciation
and amortization
|
63 | 93 | 88 | 85 | ||||||||||||||||||||
Hercules
stub-period results (c)
|
34 | - | - | - | ||||||||||||||||||||
Other
nonrecurring or noncash charges (d)
|
61 | 22 | 21 | 24 | ||||||||||||||||||||
Total
consolidated EBITDA
|
$ | 155 | $ | 227 | $ | 266 | $ | 304 | ||||||||||||||||
Reconciliation
of Debt:
|
||||||||||||||||||||||||
(In
millions)
|
Q1'09
|
Q2'09
|
Q3'09
|
Q4'09
|
||||||||||||||||||||
Total
debt (long-term and short-term)
|
$ | 2,468 | $ | 2,262 | $ | 1,993 | $ | 1,613 | ||||||||||||||||
Defeased
debt
|
(31 | ) | (31 | ) | (13 | ) | (13 | ) | ||||||||||||||||
Guarantees
(bank and third party)
|
36 | 35 | 41 | 42 | ||||||||||||||||||||
$ | 2,473 | $ | 2,266 | $ | 2,021 | $ | 1,642 | |||||||||||||||||
(a)
|
All
numbers adjusted to reflect terminology and calculation methodology
governing the senior credit agreement, included in a Form 8-K filed on
November 21, 2008, as amended.
|
(b)
|
Excludes
certain income or costs that have been specifically identified within the
senior credit agreement, as
amended.
|
(c)
|
In
accordance with the senior credit agreement, Hercules’ financial results
from October 1, 2008 through November 13, 2008, which is the period of
time during Ashland’s first quarter that it did not own Hercules, have
been included within this
calculation.
|
(d)
|
Includes
certain nonrecurring or noncash transactions, including restructuring and
integration charges, defined within the senior credit
agreement. Allowable restructuring and integration charges are
capped, per the senior credit agreement, as amended, not to exceed $80
million during the three fiscal year period ending September 30,
2011. Ashland incurred approximately $65 million of
qualifying restructuring and integration expenses in
2009.
|
Minimum
consolidated
fixed
charge
coverage
ratio
|
||||||||||||||
For
fiscal quarters ending:
|
||||||||||||||
Funding
date through September 30, 2010
|
1.25:1.00
|
|||||||||||||
December
31, 2010 through each fiscal quarter thereafter
|
1.50:1.00
|
(In
millions, except ratios) (a)
|
Q1'09
|
Q2'09
|
Q3'09
|
Q4'09
|
Total
|
Covenant
ratio
|
||||||||||||||||||
Fixed
charge coverage
|
||||||||||||||||||||||||
Consolidated
EBITDA
|
$ | 155 | $ | 227 | $ | 266 | $ | 304 | $ | 952 | ||||||||||||||
Capital
expenditures
|
57 | 42 | 27 | 67 | 193 | |||||||||||||||||||
Adjusted
interest expense
|
51 | 45 | 45 | 43 | 184 | |||||||||||||||||||
Scheduled
debt payments
|
- | 17 | 17 | 11 | 45 | |||||||||||||||||||
Adjusted
dividend payment
|
5 | 5 | 6 | 6 | 22 | |||||||||||||||||||
Fixed
charge coverage ratio
|
3.0 | x | 1.25 | x | ||||||||||||||||||||
min.
|
||||||||||||||||||||||||
(a)
|
All
numbers adjusted to reflect terminology and calculation methodology
governing the senior credit agreement, included in a Form 8-K filed on
November 21, 2008, as amended.
|
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Capital
employed
|
||||||||||||
Functional
Ingredients
|
$ | 2,684 | $ | - | $ | - | ||||||
Water
Technologies
|
1,663 | 333 | 359 | |||||||||
Performance
Materials
|
750 | 795 | 682 | |||||||||
Consumer
Markets
|
588 | 485 | 501 | |||||||||
Distribution
|
374 | 521 | 672 |
(In
millions)
|
Total
|
2010
|
2011-
2012
|
2013-
2014
|
Later
Years
|
|||||||||||||||
Contractual
obligations
|
||||||||||||||||||||
Raw
material and service contract purchase obligations (a)
|
$ | 2,661 | $ | 634 | $ | 1,356 | $ | 671 | $ | - | ||||||||||
Employee
benefit obligations (b)
|
571 | 174 | 86 | 87 | 224 | |||||||||||||||
Operating
lease obligations (c)
|
305 | 67 | 108 | 71 | 59 | |||||||||||||||
Debt (d)
|
1,613 | 76 | 130 | 631 | 776 | |||||||||||||||
Unrecognized
tax benefits
(e)
|
125 | - | - | - | 125 | |||||||||||||||
Total
contractual obligations
|
$ | 5,275 | $ | 951 | $ | 1,680 | $ | 1,460 | $ | 1,184 | ||||||||||
Other
commitments
|
||||||||||||||||||||
Letters
of credit (f)
|
$ | 136 | $ | 136 | $ | - | $ | - | $ | - | ||||||||||
(a)
|
Includes
raw material and service contracts where minimal committed quantities and
prices are fixed.
|
(b)
|
Includes
estimated funding of Ashland’s qualified U.S. and non-U.S. pension plans
for 2009, as well as projected benefit payments through 2019 under
Ashland’s unfunded pension and other postretirement benefit
plans. See Note O of Notes to Consolidated Financial Statements
for additional information.
|
(c)
|
Includes
leases for office buildings, retail outlets, transportation equipment,
warehouses and storage facilities and other equipment. For
further information, see Note K of Notes to Consolidated Financial
Statements.
|
(d)
|
Excludes
expected interest charges due to the inherent limitations in projecting
future variable interest rates and unscheduled debt
prepayments. Capitalized lease obligations are not significant
and are included in debt. For further information, see Note I
of Notes to Consolidated Financial Statements.
|
(e)
|
Due
to uncertainties in the timing of the effective settlement of tax
positions with respect to taxing authorities, Ashland is unable to
determine the timing of payments related to noncurrent unrecognized tax
benefits, including interest and penalties. Therefore, these
amounts were principally included in the “Later Years”
column.
|
(f)
|
Ashland
issues various types of letters of credit as part of its normal course of
business. For further information, see Note I of Notes to
Consolidated Financial Statements.
|
(In
millions)
|
2009
|
2008
|
(a) |
2007
|
(a) | |||||||
Increase
in pension costs from
|
||||||||||||
Decrease
in the discount rate
|
$ | 19 | $ | 16 | $ | 24 | ||||||
Increase
in the salary adjustment rate
|
9 | 7 | 9 | |||||||||
Decrease
in the expected return on plan assets
|
23 | 15 | 13 | |||||||||
Increase
in other postretirement costs from
|
||||||||||||
Decrease
in the discount rate
|
3 | 2 | 2 | |||||||||
Page | |
Management’s report on internal control over financial reporting .................................................................................................................................................................... | F-2 |
Reports of independent registered public accounting firm ................................................................................................................................................................................. | F-3 |
Consolidated
Financial Statements:
|
|
Statements of Consolidated Income ................................................................................................................................................................................................................. | F-5 |
Consolidated Balance Sheets ........................................................................................................................................................................................................................... | F-6 |
Statements of Consolidated Stockholders’ Equity......................................................................................................................................................................................... | F-7 |
Statements of Consolidated Cash Flows ........................................................................................................................................................................................................ | F-8 |
Notes to Consolidated Financial Statements .................................................................................................................................................................................................. | F-9 |
Quarterly financial information ................................................................................................................................................................................….............................................. | F-48 |
Consolidated
financial schedule:
|
|
Schedule II – Valuation and qualifying accounts .......................................................................................................................................................................................... | F-48 |
Five-year selected financial information .................................................................................................................................................................................................................. | F-49 |
Ashland
Inc. and Consolidated Subsidiaries
|
||||||||||||
Statements
of Consolidated Income
|
||||||||||||
Years
Ended September 30
|
||||||||||||
(In
millions except per share data)
|
2009
|
2008
|
2007
|
|||||||||
Sales
and operating revenues
|
$ | 8,106 | $ | 8,381 | $ | 7,785 | ||||||
Costs
and expenses
|
||||||||||||
Cost
of sales and operating expenses
|
6,317 | 7,056 | 6,447 | |||||||||
Selling,
general and administrative expenses
|
1,341 | 1,118 | 1,126 | |||||||||
Research
and development expenses
|
96 | 48 | 45 | |||||||||
7,754 | 8,222 | 7,618 | ||||||||||
Equity and other income
- Notes A & F
|
38 | 54 | 49 | |||||||||
Operating
income
|
390 | 213 | 216 | |||||||||
Net
gain (loss) on divestitures - Note C
|
59 | 20 | (3 | ) | ||||||||
Net
interest and other financing (expense) income - Note I
|
(205 | ) | 28 | 46 | ||||||||
Other
expenses
|
(86 | ) | - | - | ||||||||
Income
from continuing operations before income taxes
|
158 | 261 | 259 | |||||||||
Income
tax expense - Note L
|
80 | 86 | 58 | |||||||||
Income
from continuing operations
|
78 | 175 | 201 | |||||||||
(Loss)
income from discontinued operations (net of income taxes) - Note
E
|
(7 | ) | (8 | ) | 29 | |||||||
Net
income
|
$ | 71 | $ | 167 | $ | 230 | ||||||
Earnings
per share - Note A
|
||||||||||||
Basic
|
||||||||||||
Income
from continuing operations
|
$ | 1.08 | $ | 2.78 | $ | 3.20 | ||||||
(Loss)
income from discontinued operations
|
(0.10 | ) | (0.13 | ) | 0.46 | |||||||
Net
income
|
$ | 0.98 | $ | 2.65 | $ | 3.66 | ||||||
Diluted
|
||||||||||||
Income
from continuing operations
|
$ | 1.07 | $ | 2.76 | $ | 3.15 | ||||||
(Loss)
income from discontinued operations
|
(0.11 | ) | (0.13 | ) | 0.45 | |||||||
Net
income
|
$ | 0.96 | $ | 2.63 | $ | 3.60 |
Ashland
Inc. and Consolidated Subsidiaries
|
||||||||
Consolidated
Balance Sheets
|
||||||||
At
September 30
|
||||||||
(In
millions)
|
2009
|
2008
|
||||||
Assets
|
||||||||
Current
assets
|
||||||||
Cash
and cash equivalents
|
$ | 352 | $ | 886 | ||||
Accounts
receivable (less allowances for doubtful accounts of
|
||||||||
$38
million in 2009 and $33 million in 2008) - Note A
|
1,404 | 1,441 | ||||||
Inventories
- Note A
|
554 | 476 | ||||||
Deferred
income taxes - Note L
|
115 | 97 | ||||||
Other
current assets
|
46 | 79 | ||||||
Current
assets held for sale - Note C
|
2 | 47 | ||||||
2,473 | 3,026 | |||||||
Noncurrent
assets
|
||||||||
Auction
rate securities - Note G
|
170 | 243 | ||||||
Goodwill
- Note H
|
2,220 | 283 | ||||||
Intangibles
- Note H
|
1,204 | 109 | ||||||
Asbestos
insurance receivable (noncurrent portion) - Note P
|
510 | 428 | ||||||
Deferred
income taxes - Note L
|
161 | 153 | ||||||
Other
noncurrent assets - Note J
|
596 | 388 | ||||||
Noncurrent
assets held for sale - Note C
|
17 | 46 | ||||||
4,878 | 1,650 | |||||||
Property, plant and
equipment - Note A
|
||||||||
Cost
|
||||||||
Land
|
258 | 82 | ||||||
Buildings
|
723 | 552 | ||||||
Machinery
and equipment
|
2,317 | 1,497 | ||||||
Construction
in progress
|
195 | 140 | ||||||
3,493 | 2,271 | |||||||
Accumulated
depreciation and amortization
|
(1,397 | ) | (1,176 | ) | ||||
2,096 | 1,095 | |||||||
$ | 9,447 | $ | 5,771 | |||||
Liabilities and
Stockholders’ Equity
|
||||||||
Current
liabilities
|
||||||||
Short-term
debt - Note I
|
$ | 23 | $ | - | ||||
Current
portion of long-term debt - Note I
|
53 | 21 | ||||||
Trade
and other payables
|
949 | 918 | ||||||
Accrued
expenses and other liabilities
|
541 | 278 | ||||||
Current
liabilities held for sale - Note C
|
- | 13 | ||||||
1,566 | 1,230 | |||||||
Noncurrent
liabilities
|
||||||||
Long-term
debt (noncurrent portion) - Note I
|
1,537 | 45 | ||||||
Employee
benefit obligations - Note O
|
1,214 | 344 | ||||||
Asbestos
litigation reserve (noncurrent portion) - Note P
|
956 | 522 | ||||||
Other
noncurrent liabilities - Note J
|
590 | 428 | ||||||
4,297 | 1,339 | |||||||
Stockholders’ equity -
Notes M and N
|
||||||||
Common
stock, par value $.01 per share, 200 million shares
authorized
|
||||||||
Issued
- 75 million shares in 2009 and 63 million shares in 2008
|
1 | 1 | ||||||
Paid-in
capital
|
521 | 33 | ||||||
Retained
earnings
|
3,185 | 3,138 | ||||||
Accumulated
other comprehensive (loss) income
|
(123 | ) | 30 | |||||
3,584 | 3,202 | |||||||
$ | 9,447 | $ | 5,771 |
Ashland
Inc. and Consolidated Subsidiaries
|
||||||||||||||||||||
Statements
of Consolidated Stockholders' Equity
|
||||||||||||||||||||
(In
millions)
|
Common
stock
|
Paid-in
capital
|
Retained
earnings
|
Accumulated
other
comprehensive
income
(loss)
|
(a) |
Total
|
||||||||||||||
Balance
at September 30, 2006
|
$ | 1 | $ | 240 | $ | 2,899 | $ | (44 | ) | $ | 3,096 | |||||||||
Total
comprehensive income (b)
|
230 | 184 | 414 | |||||||||||||||||
Regular
dividends, $1.10 per common share
|
(1 | ) | (68 | ) | (69 | ) | ||||||||||||||
Issued
728,839 common shares under
|
||||||||||||||||||||
stock
incentive and other plans (c)
|
44 | 44 | ||||||||||||||||||
Adoption
of FAS 158, net of $27 million tax benefits
|
(43 | ) | (43 | ) | ||||||||||||||||
Repurchase
of 4,712,000 common shares - Note M
|
(267 | ) | (21 | ) | (288 | ) | ||||||||||||||
Balance
at September 30, 2007
|
1 | 16 | 3,040 | 97 | 3,154 | |||||||||||||||
Total
comprehensive income (loss) (b)
|
167 | (67 | ) | 100 | ||||||||||||||||
Regular
dividends, $1.10 per common share
|
(69 | ) | (69 | ) | ||||||||||||||||
Issued
151,821 common shares under
|
||||||||||||||||||||
stock
incentive and other plans (c)
|
17 | 17 | ||||||||||||||||||
Balance
at September 30, 2008
|
1 | 33 | 3,138 | 30 | 3,202 | |||||||||||||||
Total
comprehensive income (loss) (b)
|
71 | (153 | ) | (82 | ) | |||||||||||||||
Regular
dividends, $.30 per common share
|
(22 | ) | (22 | ) | ||||||||||||||||
Issuance
of common shares - Note M
|
450 | 450 | ||||||||||||||||||
Issued
1,353,880 common shares under
|
||||||||||||||||||||
stock
incentive and other plans (c) (d)
|
42 | 42 | ||||||||||||||||||
Other
|
(4 | ) | (2 | ) | (6 | ) | ||||||||||||||
Balance
at September 30, 2009
|
$ | 1 | $ | 521 | $ | 3,185 | $ | (123 | ) | $ | 3,584 | |||||||||
|
(a) |
At
September 30, 2009 and 2008, the accumulated other comprehensive (loss)
income (after-tax) of ($123) million for 2009 and $30 million for 2008 was
comprised of unfunded pension and postretirement obligations of $462
million for 2009 and $107 million for 2008, net unrealized translation
gains of $339 million for 2009 and $157 million for 2008 and net
unrealized losses on investment securities of $20 million during
2008.
|
|||||||||||||
(b) |
Reconciliations
of net income to total comprehensive (loss) income follow.
|
|||||||||||||
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||||
Net
income
|
$ | 71 | $ | 167 | $ | 230 | ||||||||
Pension
and postretirement obligation adjustment, net of tax
|
(355 | ) | (51 | ) | 101 | |||||||||
Unrealized
translation gain, net of tax
|
182 | 4 | 82 | |||||||||||
Net
unrealized gain (loss) on investment securities, net of
tax
|
20 | (20 | ) | - | ||||||||||
Unrealized
gains on cash flow hedges, net of tax
|
- | - | 1 | |||||||||||
Total
comprehensive (loss) income
|
$ | (82 | ) | $ | 100 | $ | 414 | |||||||
(c) |
Includes
income tax benefits resulting from the exercise of stock options of $2
million in 2009, $2 million in 2008 and $12 million in
2007.
|
|||||||||||||
(d) |
Includes
$10 million from the fair value of Hercules stock options converted into
stock options for Ashland
shares.
|
Ashland
Inc. and Consolidated Subsidiaries
|
||||||||||||
Statements
of Consolidated Cash Flows
|
||||||||||||
Years
Ended September 30
|
||||||||||||
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Cash
flows provided by operating activities from continuing
operations
|
||||||||||||
Net
income
|
$ | 71 | $ | 167 | $ | 230 | ||||||
Loss
(income) from discontinued operations (net of income
taxes)
|
7 | 8 | (29 | ) | ||||||||
Adjustments
to reconcile income from continuing operations
|
||||||||||||
to
cash flows from operating activities
|
||||||||||||
Depreciation
and amortization
|
329 | 145 | 133 | |||||||||
Debt
issuance cost amortization
|
52 | - | - | |||||||||
Purchased
in-process research and development amortization
|
10 | - | - | |||||||||
Deferred
income taxes
|
12 | 44 | 22 | |||||||||
Equity
income from affiliates
|
(14 | ) | (23 | ) | (15 | ) | ||||||
Distributions
from equity affiliates
|
15 | 13 | 10 | |||||||||
Gain
from the sale of property and equipment
|
(2 | ) | (2 | ) | (4 | ) | ||||||
Stock
based compensation expense - Note N
|
9 | 12 | 16 | |||||||||
Stock
contributions to qualified savings plans
|
13 | - | - | |||||||||
Net
(gain) loss on divestitures - Note C
|
(59 | ) | (20 | ) | 3 | |||||||
Inventory
fair value adjustment related to Hercules acquisition
|
37 | - | - | |||||||||
Loss
on currency swaps related to Hercules acquisition
|
54 | - | - | |||||||||
Loss
on auction rate securities
|
32 | - | - | |||||||||
Change
in operating assets and liabilities (a)
|
461 | 134 | (177 | ) | ||||||||
1,027 | 478 | 189 | ||||||||||
Cash
flows used by investing activities from continuing
operations
|
||||||||||||
Additions
to property, plant and equipment
|
(174 | ) | (205 | ) | (154 | ) | ||||||
Proceeds
from the disposal of property, plant and equipment
|
47 | 10 | 27 | |||||||||
Purchase
of operations - net of cash acquired
|
(2,080 | ) | (129 | ) | (75 | ) | ||||||
Proceeds
from sale of operations
|
114 | 26 | - | |||||||||
Settlement
of currency swaps related to Hercules acquisition
|
(95 | ) | - | - | ||||||||
Purchases
of available-for-sale securities
|
- | (435 | ) | (484 | ) | |||||||
Proceeds
from sales and maturities of available-for-sale securities
|
73 | 315 | 680 | |||||||||
(2,115 | ) | (418 | ) | (6 | ) | |||||||
Cash
flows provided (used) by financing activities from continuing
operations
|
||||||||||||
Proceeds
from the issuance of long-term debt
|
2,628 | - | - | |||||||||
Repayment
of long-term debt
|
(1,862 | ) | (5 | ) | (13 | ) | ||||||
Proceeds
from/repayments of issuance of short-term debt
|
(19 | ) | - | - | ||||||||
Debt
issuance/modification costs
|
(162 | ) | - | - | ||||||||
Cash
dividends paid
|
(22 | ) | (69 | ) | (743 | ) | ||||||
Proceeds
from the exercise of stock options
|
9 | 3 | 19 | |||||||||
Excess
tax benefits related to share-based payments
|
1 | 1 | 9 | |||||||||
Repurchase
of common stock
|
- | - | (288 | ) | ||||||||
573 | (70 | ) | (1,016 | ) | ||||||||
Cash
used by continuing operations
|
(515 | ) | (10 | ) | (833 | ) | ||||||
Cash
used by discontinued operations
|
||||||||||||
Operating
cash flows
|
(2 | ) | (8 | ) | (3 | ) | ||||||
Investing
cash flows
|
- | - | (92 | ) | ||||||||
(2 | ) | (8 | ) | (95 | ) | |||||||
Effect
of currency exchange rate changes on cash and cash
equivalents
|
(17 | ) | 7 | 5 | ||||||||
Decrease
in cash and cash equivalents
|
(534 | ) | (11 | ) | (923 | ) | ||||||
Cash
and cash equivalents - beginning of year
|
886 | 897 | 1,820 | |||||||||
Cash
and cash equivalents - end of year
|
$ | 352 | $ | 886 | $ | 897 | ||||||
(Increase) decrease in
operating assets (a)
|
||||||||||||
Accounts
receivable
|
$ | 405 | $ | 10 | $ | (56 | ) | |||||
Inventories
|
147 | 126 | (75 | ) | ||||||||
Other
current assets
|
102 | (53 | ) | (22 | ) | |||||||
Investments
and other assets
|
12 | 78 | 90 | |||||||||
Increase (decrease) in
operating liabilities (a)
|
||||||||||||
Trade
and other payables
|
(208 | ) | 57 | (103 | ) | |||||||
Other
current liabilities
|
13 | (7 | ) | (20 | ) | |||||||
Pension
contributions
|
(47 | ) | (25 | ) | (58 | ) | ||||||
Other
noncurrent liabilities
|
37 | (52 | ) | 67 | ||||||||
Change
in operating assets and liabilities
|
$ | 461 | $ | 134 | $ | (177 | ) | |||||
Supplemental
disclosures
|
||||||||||||
Interest
paid
|
$ | 198 | $ | 10 | $ | 10 | ||||||
Income
taxes paid
|
49 | 53 | 25 | |||||||||
(In
millions)
|
2009
|
2008
|
(a) | |||||
Finished
products
|
$ | 567 | $ | 644 | ||||
Raw
materials, supplies and work in process
|
112 | 32 | ||||||
LIFO
carrying values
|
(125 | ) | (200 | ) | ||||
$ | 554 | $ | 476 | |||||
(In
millions except per share data)
|
2009
|
2008
|
2007
|
|||||||||
Numerator
|
||||||||||||
Numerator
for basic and diluted EPS -
|
||||||||||||
Income
from continuing operations
|
$ | 78 | $ | 175 | $ | 201 | ||||||
Denominator
|
||||||||||||
Denominator
for basic EPS - Weighted-average
|
||||||||||||
common
shares outstanding
|
72 | 63 | 63 | |||||||||
Share
based awards convertible to common shares
|
1 | 1 | 1 | |||||||||
Denominator
for diluted EPS - Adjusted weighted-
|
||||||||||||
average
shares and assumed conversions
|
73 | 64 | 64 | |||||||||
EPS
from continuing operations
|
||||||||||||
Basic
|
$ | 1.08 | $ | 2.78 | $ | 3.20 | ||||||
Diluted
|
1.07 | 2.76 | 3.15 |
Purchase
price (in millions)
|
|||||
Cash
consideration for stock
|
$
|
2,096
|
(a)
|
||
Stock
consideration
|
450
|
(b)
|
|||
Cash
consideration for Restricted Stock Units (RSUs)
|
5
|
(c)
|
|||
Options
|
|||||
Cash-out
options
|
15
|
(d)
|
|||
Fair
value of Hercules stock options converted into stock options
for Ashland shares
|
10
|
(e)
|
|||
Transaction
costs
|
18
|
(f)
|
|||
Total
purchase price
|
$
|
2,594
|
|||
(a)
|
The
cash portion ($18.60) of the merger consideration paid per outstanding
share of Hercules Common
Stock.
|
(b)
|
The
stock portion of the merger consideration was based on 0.0930 of a share
of Ashland Common Stock for each share of Hercules Common
Stock. A price of $42.93 per Ashland common share was assumed,
which represents the average closing price per share of Ashland Common
Stock on the New York Stock Exchange (NYSE) on the announcement date two
days immediately prior to and immediately subsequent to the announcement
date of the proposed acquisition in accordance with U.S.
GAAP.
|
(c)
|
The
cash payment for RSUs was calculated by multiplying the number of shares
of Hercules Common Stock underlying the RSUs by the cash-out amount, which
is the sum of $18.60 and the product of 0.0930 and the average closing
price of Ashland Common Stock on the NYSE for the ten trading days
preceding the completion of the merger. Hercules RSUs
represented the equivalent of approximately 240 thousand
shares.
|
(d)
|
The
cash payment for certain stock options was equal to the product of the
number of Hercules shares subject to the option and the amount by which
the exercise price of the Hercules option is exceeded by the sum of $18.60
and the amount calculated by multiplying 0.0930 by the average closing
price of Ashland Common Stock on the NYSE for the ten trading days
preceding the completion of the
merger.
|
(e)
|
Approximately one million of
Hercules’ stock options were converted into options to purchase shares of
Ashland Common Stock based on the option exchange ratio set forth in the
merger agreement. The fair value of Hercules’ stock options
that were converted into options to purchase shares of Ashland Common
Stock were recognized as a component of the purchase price, based on the
fair value of the options, as described below. The additional
purchase price was calculated using the Black-Scholes option pricing
model, which considered a price of $42.93 per Ashland common share assumed
and the following weighted-average
assumptions.
|
Black-Scholes
|
||||
Expected
option life (in years)
|
1.3 | |||
Volatility
|
26.0 | % | ||
Risk-free
rate
|
0.7 | % | ||
Dividend
yield
|
1.2 | % |
(f)
|
Ashland’s
costs for various legal and financial services associated with the
transaction.
|
Purchase
price allocation (in millions)
|
At
November
13
2008
|
|||
Assets:
|
||||
Cash
|
$ | 54 | ||
Accounts
receivable
|
355 | |||
Inventory
|
261 | |||
Other
current assets
|
57 | |||
Intangible
assets
|
1,116 | |||
Goodwill
|
1,806 | |||
Asbestos
receivable
|
118 | |||
Property,
plant and equipment
|
1,059 | |||
Purchased
in-process research and development
|
10 | |||
Other
noncurrent assets
|
164 | |||
Liabilities:
|
||||
Accounts
payable
|
(231 | ) | ||
Accrued
expenses
|
(215 | ) | ||
Debt
|
(799 | ) | ||
Pension
and other postretirement obligations
|
(316 | ) | ||
Environmental
|
(100 | ) | ||
Asbestos
|
(494 | ) | ||
Deferred
tax - net
|
(129 | ) | ||
Other
noncurrent liabilities
|
(122 | ) | ||
Total
purchase price
|
$ | 2,594 |
(In
millions)
|
|||||
Functional
Ingredients
|
Corebond
|
$ | 2 | ||
Water
Technologies
|
Biofilm
Sensor
|
$ | 2 | ||
Water
Technologies
|
Surface
Dry Strength
|
$ | 2 | ||
Functional
Ingredients / Water Technologies
|
Other
|
$ | 4 |
Intangible
asset type (in millions)
|
Value
|
Life
(years)
|
||||||
Customer
relationships - Functional Ingredients
|
$ | 289 | 10 - 24 | |||||
Customer
relationships - Water Technologies
|
240 | 12 | ||||||
Developed
technology - Functional Ingredients
|
217 | 15 | ||||||
Developed
technology - Water Technologies
|
60 | 5 - 20 | ||||||
Product
trade names - Functional Ingredients
|
32 | 20 | ||||||
Product
trade names - Functional Ingredients
|
104 |
Indefinite
|
||||||
Product
trade names - Water Technologies
|
151 |
Indefinite
|
||||||
Other
|
23 | 36 - 47 | ||||||
Total
|
$ | 1,116 |
Unaudited
pro forma information
|
Fiscal
year ended
September
30
|
|||||||
(In
millions, except per share amounts)
|
2009
|
2008
|
||||||
Revenues
|
$ | 8,373 | $ | 10,699 | ||||
Income
from continuing operations
|
$ | 239 | $ | 183 | ||||
Net
income
|
$ | 232 | $ | 208 | ||||
Basic
earnings per share
|
||||||||
Income
from continuing operations
|
$ | 3.22 | $ | 2.49 | ||||
Net
income
|
$ | 3.12 | $ | 2.83 | ||||
Diluted
earnings per share
|
||||||||
Income
from continuing operations
|
$ | 3.16 | $ | 2.45 | ||||
Net
income
|
$ | 3.07 | $ | 2.78 |
(In
millions - unaudited)
|
September
30
2008
|
|||
Accounts
receivable
|
$ | 28 | ||
Inventories
|
19 | |||
Current
assets
|
$ | 47 | ||
Property,
plant and equipment, net
|
$ | 2 | ||
Goodwill
and intangible assets
|
16 | |||
Deferred
income tax
|
1 | |||
Other
noncurrent assets
|
5 | |||
Noncurrent
assets
|
$ | 24 | ||
Trade
payables
|
$ | 12 | ||
Accrued
expenses and other liabilities
|
1 | |||
Current
liabilities
|
$ | 13 |
(In
millions)
|
Severance
|
Plant
closure/
other
costs
|
Total
|
|||||||||
Balance
as of September 30, 2007
|
$ | - | $ | - | $ | - | ||||||
Restructuring
reserve
|
9 | - | 9 | |||||||||
Utilization
(cash paid or otherwise settled)
|
(2 | ) | - | (2 | ) | |||||||
Balance
as of September 30, 2008
|
7 | - | 7 | |||||||||
Restructuring
reserve
|
75 | 21 | 96 | |||||||||
Utilization
(cash paid or otherwise settled)
|
(44 | ) | (21 | ) | (65 | ) | ||||||
Balance
at September 30, 2009
|
$ | 38 | $ | - | $ | 38 |
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Income
(loss) from discontinued operations
|
||||||||||||
APAC
|
$ | 1 | $ | - | $ | - | ||||||
Asbestos-related
litigation reserves, expenses and related receivables
|
2 | (11 | ) | 35 | ||||||||
Loss
on disposal of discontinued operations
|
||||||||||||
APAC
|
- | - | (6 | ) | ||||||||
Electronic
Chemicals
|
(4 | ) | - | (1 | ) | |||||||
Income
(loss) before income taxes
|
(1 | ) | (11 | ) | 28 | |||||||
Income
tax (expense) benefit
|
||||||||||||
Benefit
(expense) related to income (loss) from discontinued
operations
|
||||||||||||
APAC
|
(1 | ) | 1 | 2 | ||||||||
Asbestos-related
litigation reserves and expenses
|
- | 9 | - | |||||||||
Benefit
(expense) related to gain (loss) on disposal of discontinued
operations
|
||||||||||||
APAC
|
(6 | ) | (7 | ) | (1 | ) | ||||||
Electronic
Chemicals
|
1 | - | - | |||||||||
Income
(loss) from discontinued operations (net of income taxes)
|
$ | (7 | ) | $ | (8 | ) | $ | 29 |
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Financial
position
|
||||||||||||
Current
assets
|
$ | 226 | $ | 254 | ||||||||
Current
liabilities
|
(89 | ) | (120 | ) | ||||||||
Working
capital
|
137 | 134 | ||||||||||
Noncurrent
assets
|
66 | 71 | ||||||||||
Noncurrent
liabilities
|
(8 | ) | (9 | ) | ||||||||
Stockholders'
equity
|
$ | 195 | $ | 196 | ||||||||
Results
of operations
|
||||||||||||
Sales
and operating revenues
|
$ | 517 | $ | 655 | $ | 514 | ||||||
Income
from operations
|
52 | 75 | 51 | |||||||||
Net
income
|
32 | 52 | 42 | |||||||||
Amounts
recorded by Ashland
|
||||||||||||
Investments
and advances
|
$ | 79 | $ | 81 | $ | 73 | ||||||
Equity
income
|
14 | 23 | 15 | |||||||||
Distributions
received
|
15 | 13 | 10 |
(In
millions)
|
Carrying
Value
|
Total
fair
value
|
Quoted
prices
in
active
markets
for
identical
assets
Level
1
|
Significant
other
observable
inputs
Level
2
|
Significant
unobservable
inputs
Level
3
|
|||||||||||||||
Assets
|
||||||||||||||||||||
Cash
and cash equivalents
|
$ | 352 | $ | 352 | $ | 352 | $ | - | $ | - | ||||||||||
Auction
rate securities
|
170 | 170 | - | - | 170 | |||||||||||||||
Deferred
compensation investments (a)
|
175 | 175 | 69 | 106 | - | |||||||||||||||
Investment
of captive insurance company (a)
|
3 | 3 | 3 | - | - | |||||||||||||||
Total
assets at fair value
|
$ | 700 | $ | 700 | $ | 424 | $ | 106 | $ | 170 | ||||||||||
(In
millions)
|
Amortized
cost
|
Fair
value
|
||||||
Over
10 years
|
$ | 192 | $ | 170 |
(In
millions)
|
Level
3
|
|||
Balance
as of October 1, 2008 (par value)
|
$ | 275 | ||
Unrealized
losses as of October 1, 2008 included in other comprehensive
income
|
(32 | ) | ||
Recorded
balance as of October 1, 2008
|
243 | |||
Transfers
in and/or (out) of Level 3
|
- | |||
Total
losses charged in the Consolidated Statement of Income
|
(32 | ) | ||
Total
reversal of losses included in other comprehensive income
|
32 | |||
Sales
of auction rate securities
|
(73 | ) | ||
Balance
as of September 30, 2009
|
$ | 170 |
(In
millions)
|
Functional
Ingredients
|
Water
Technologies
|
(a) |
Performance
Materials
|
(b) |
Consumer
Markets
|
Distribution
|
Total
|
||||||||||||||||
Balance
at September 30, 2007
|
$ | - | $ | 54 | $ | 166 | $ | 30 | $ | 1 | $ | 251 | ||||||||||||
Acquisitions
|
- | 1 | 28 | - | - | 29 | ||||||||||||||||||
Currency
translation adjustment
|
- | 1 | 2 | - | - | 3 | ||||||||||||||||||
Balance
at September 30, 2008
|
- | 56 | 196 | 30 | 1 | 283 | ||||||||||||||||||
Acquisitions
|
1,030 | 515 | 97 | 85 | 79 | 1,806 | ||||||||||||||||||
Currency
translation adjustment
|
76 | 55 | - | - | - | 131 | ||||||||||||||||||
Balance
at September 30, 2009
|
$ | 1,106 | $ | 626 | $ | 293 | $ | 115 | $ | 80 | $ | 2,220 | ||||||||||||
(a)
|
Excludes
goodwill of $16 million as of September 30, 2008 associated with the Drew
Marine sale during 2009 that has been classified within assets held for
sale.
|
(b)
|
Goodwill
consisted of $51 million and $242 million, respectively, for the Casting
Solutions and Composites and Adhesives reporting
units.
|
2009 | 2008 | |||||||||||||||||||||||
(In
millions)
|
Gross
carrying
amount
|
Accumulated
amortization
|
Net
carrying
amount
|
Gross
carrying
amount
|
Accumulated
amortization
|
Net
carrying
amount
|
||||||||||||||||||
Trademarks
and trade names
|
$ | 353 | $ | (24 | ) | $ | 329 | $ | 67 | $ | (22 | ) | $ | 45 | ||||||||||
Intellectual
property
|
331 | (41 | ) | 290 | 54 | (21 | ) | 33 | ||||||||||||||||
Customer
relationships
|
586 | (40 | ) | 546 | 13 | (3 | ) | 10 | ||||||||||||||||
Other
intangibles
|
63 | (24 | ) | 39 | 38 | (17 | ) | 21 | ||||||||||||||||
Total
intangible assets
|
$ | 1,333 | $ | (129 | ) | $ | 1,204 | $ | 172 | $ | (63 | ) | $ | 109 |
|
2009
|
2008
|
||||||
Term
loan A, due 2013 (a)
|
$ | 219 | $ | - | ||||
Term
loan B, due 2014 (a)
|
542 | - | ||||||
6.60%
notes, due 2027 (b)
|
12 | - | ||||||
9.125%
notes, due 2017
|
628 | - | ||||||
Medium-term
notes, due 2013-2019, interest at a weighted-
|
||||||||
average
rate of 8.4% at September 30, 2009 (7.7% to 9.4%)
|
21 | 21 | ||||||
8.80%
debentures, due 2012
|
20 | 20 | ||||||
6.86%
medium-term notes, Series H, due 2009
|
- | 17 | ||||||
Hercules
Tianpu - term notes, due through 2011 (b)
|
19 | - | ||||||
6.50%
junior subordinated notes, due 2029 (b)
|
125 | - | ||||||
International
revolver agreements
|
22 | - | ||||||
Other
|
5 | 8 | ||||||
Total
debt
|
1,613 | 66 | ||||||
Short-term
debt
|
(23 | ) | - | |||||
Current
portion of long-term debt
|
(53 | ) | (21 | ) | ||||
Long-term
debt (less current portion)
|
$ | 1,537 | $ | 45 | ||||
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Interest
income
|
$ | 21 | $ | 40 | $ | 59 | ||||||
Interest
expense
|
(215 | ) | (9 | ) | (10 | ) | ||||||
Other
financing costs
|
(11 | ) | (3 | ) | (3 | ) | ||||||
$ | (205 | ) | $ | 28 | $ | 46 |
Maximum
consolidated
leverage
ratio
|
||||||||||||||
For
fiscal quarters ending:
|
||||||||||||||
Funding
date through September 30, 2009
|
3.75:1.00
|
|||||||||||||
December
31, 2009 through September 30, 2010
|
3.50:1.00
|
|||||||||||||
December
31, 2010 through September 30, 2011
|
3.00:1.00
|
|||||||||||||
December
31, 2011 through September 30, 2012
|
2.75:1.00
|
|||||||||||||
December
31, 2012 and each fiscal quarter thereafter
|
2.50:1.00
|
(In
millions, except ratios) (a)
|
Q1'09
|
Q2'09
|
Q3'09
|
Q4'09
|
Total
|
Covenant
ratio
|
||||||||||||||||||
Debt/EBITDA
|
||||||||||||||||||||||||
Consolidated
EBITDA
|
$ | 155 | $ | 227 | $ | 266 | $ | 304 | $ | 952 | ||||||||||||||
Debt
|
2,473 | 2,266 | 2,021 | 1,642 | 1,642 | |||||||||||||||||||
Debt/EBITDA
|
1.7 | x | 3.75 | x | ||||||||||||||||||||
max.
|
||||||||||||||||||||||||
Reconciliation
of Consolidated EBITDA:
|
||||||||||||||||||||||||
(In
millions)
|
Q1'09
|
Q2'09
|
Q3'09
|
Q4'09
|
||||||||||||||||||||
Net
(loss) income
|
$ | (119 | ) | $ | 48 | $ | 50 | $ | 93 | |||||||||||||||
Key
items excluded (b)
|
82 | (1 | ) | 3 | - | |||||||||||||||||||
Consolidated
interest charges
|
35 | 56 | 64 | 63 | ||||||||||||||||||||
Income
taxes (benefit) expense
|
(1 | ) | 9 | 40 | 39 | |||||||||||||||||||
Depreciation
and amortization
|
63 | 93 | 88 | 85 | ||||||||||||||||||||
Hercules
stub-period results (c)
|
34 | - | - | - | ||||||||||||||||||||
Other
nonrecurring or noncash charges (d)
|
61 | 22 | 21 | 24 | ||||||||||||||||||||
Total
consolidated EBITDA
|
$ | 155 | $ | 227 | $ | 266 | $ | 304 | ||||||||||||||||
Reconciliation
of Debt:
|
||||||||||||||||||||||||
(In
millions)
|
Q1'09
|
Q2'09
|
Q3'09
|
Q4'09
|
||||||||||||||||||||
Total
debt (long-term and short-term)
|
$ | 2,468 | $ | 2,262 | $ | 1,993 | $ | 1,613 | ||||||||||||||||
Defeased
debt
|
(31 | ) | (31 | ) | (13 | ) | (13 | ) | ||||||||||||||||
Guarantees
(bank and third party)
|
36 | 35 | 41 | 42 | ||||||||||||||||||||
$ | 2,473 | $ | 2,266 | $ | 2,021 | $ | 1,642 | |||||||||||||||||
(a)
|
All
numbers adjusted to reflect terminology and calculation methodology
governing the senior credit agreement, included in a Form 8-K filed on
November 21, 2008, as amended.
|
(b)
|
Excludes
certain income or costs that have been specifically identified within the
senior credit agreement, as
amended.
|
(c)
|
In
accordance with the senior credit agreement, Hercules’ financial results
from October 1, 2008 through November 13, 2008, which is the period of
time during Ashland’s first quarter that it did not own Hercules, have
been included within this
calculation.
|
(d)
|
Includes
certain nonrecurring or noncash transactions, including restructuring and
integration charges, defined within the senior credit
agreement. Allowable restructuring and integration charges are
capped, per the senior credit agreement, as amended, not to exceed $80
million during the three fiscal year period ending September 30,
2011. Ashland incurred approximately $65 million of
qualifying restructuring and integration expenses in
2009.
|
Minimum
consolidated
fixed
charge
coverage
ratio
|
||||||||||||||
For
fiscal quarters ending:
|
||||||||||||||
Funding
date through September 30, 2010
|
1.25:1.00
|
|||||||||||||
December
31, 2010 through each fiscal quarter thereafter
|
1.50:1.00
|
(In
millions, except ratios) (a)
|
Q1'09
|
Q2'09
|
Q3'09
|
Q4'09
|
Total
|
Covenant
ratio
|
||||||||||||||||||
Fixed
charge coverage
|
||||||||||||||||||||||||
Consolidated
EBITDA
|
$ | 155 | $ | 227 | $ | 266 | $ | 304 | $ | 952 | ||||||||||||||
Capital
expenditures
|
57 | 42 | 27 | 67 | 193 | |||||||||||||||||||
Adjusted
interest expense
|
51 | 45 | 45 | 43 | 184 | |||||||||||||||||||
Scheduled
debt payments
|
- | 17 | 17 | 11 | 45 | |||||||||||||||||||
Adjusted
dividend payment
|
5 | 5 | 6 | 6 | 22 | |||||||||||||||||||
Fixed
charge coverage ratio
|
3.0 | x | 1.25 | x | ||||||||||||||||||||
min.
|
(a)
|
All
numbers adjusted to reflect terminology and calculation methodology
governing the senior credit agreement, included in a Form 8-K filed on
November 21, 2008, as amended.
|
(In
millions)
|
2009
|
2008
|
||||||
Deferred
compensation investments
|
$ | 175 | $ | 127 | ||||
Debt
issuance cost
|
112 | - | ||||||
Equity
investments
|
79 | 81 | ||||||
Tax
receivables
|
42 | 49 | ||||||
Environmental
insurance receivables
|
35 | 40 | ||||||
Defined
benefit plan assets
|
32 | - | ||||||
Debt
defeasance assets
|
18 | 18 | ||||||
Note
receivables
|
14 | 20 | ||||||
Investments
of captive insurance companies
|
3 | 26 | ||||||
Other
|
86 | 27 | ||||||
$ | 596 | $ | 388 |
(In
millions)
|
2009
|
2008
|
||||||
Environmental
remediation reserves
|
$ | 169 | $ | 112 | ||||
Accrued
tax liabilities (including sales and franchise)
|
145 | 81 | ||||||
Deferred
compensation
|
93 | 101 | ||||||
Insurance
reserves related to workers compensation and general
liability
|
86 | 82 | ||||||
Other
|
97 | 52 | ||||||
$ | 590 | $ | 428 |
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Minimum
rentals (including rentals under short-term leases)
|
$ | 78 | $ | 59 | $ | 60 | ||||||
Contingent
rentals
|
3 | 3 | 3 | |||||||||
Sublease
rental income
|
(6 | ) | (1 | ) | (2 | ) | ||||||
$ | 75 | $ | 61 | $ | 61 |
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Current
|
||||||||||||
Federal
|
$ | 9 | $ | 13 | $ | 5 | ||||||
State
|
3 | 3 | (7 | ) | ||||||||
Foreign
|
68 | 26 | 38 | |||||||||
80 | 42 | 36 | ||||||||||
Deferred
|
- | 44 | 22 | |||||||||
Income
tax expense
|
$ | 80 | $ | 86 | $ | 58 |
(In
millions)
|
2009
|
2008
|
||||||
Deferred
tax assets
|
||||||||
Employee
benefit obligations
|
$ | 431 | $ | 124 | ||||
Environmental,
self-insurance and litigation reserves (net of
receivables)
|
247 | 78 | ||||||
Credit
carryforwards (a)
|
152 | - | ||||||
Foreign
net operating loss carryforwards (b)
|
106 | 29 | ||||||
State
net operating loss carryforwards (c)
|
101 | - | ||||||
Federal
capital loss carryforwards (d)
|
73 | - | ||||||
Compensation
accruals
|
79 | 75 | ||||||
Uncollectible
accounts receivable
|
12 | 9 | ||||||
Other
items
|
80 | 56 | ||||||
Valuation
allowances (e)
|
(306 | ) | (26 | ) | ||||
Total
deferred tax assets
|
975 | 345 | ||||||
Deferred
tax liabilities
|
||||||||
Property,
plant and equipment
|
295 | 75 | ||||||
Goodwill
and other intangibles (f)
|
277 | 10 | ||||||
Investment
in unconsolidated affiliates
|
127 | 10 | ||||||
Total
deferred tax liabilities
|
699 | 95 | ||||||
Net
deferred tax asset
|
$ | 276 | $ | 250 | ||||
(a)
|
Consists
of foreign tax credits of $134 million expiring over 2012 to 2018,
alternative minimum tax credits of $11 million with no expiration and
research and development credits of $7 million expiring over 2022 to
2029.
|
(b)
|
Foreign
net operating loss carryforwards will expire in future years as follows:
$1 million in 2010, $1 million in 2011 and the remaining balance in other
future years.
|
(c)
|
State
net operating loss carryforwards will expire in future years as
follows: $42 million in 2010, $30 million in 2011 and the
remaining balance in other future
years.
|
(d)
|
Federal
capital loss carryforwards will expire in
2014.
|
(e)
|
Valuation
allowances primarily relate to the realization of recorded tax benefits on
U.S. federal, state and foreign net operating loss carryforwards as well
as capital losses.
|
(f)
|
The
total amount of goodwill as of September 30, 2009 expected to be
deductible for tax purposes is $110
million.
|
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Income
(loss) from continuing operations before income taxes
|
||||||||||||
United
States
|
$ | 30 | $ | 174 | $ | 163 | ||||||
Foreign
|
128 | 87 | 96 | |||||||||
$ | 158 | $ | 261 | $ | 259 | |||||||
Income
taxes computed at U.S. statutory rate (35%)
|
$ | 55 | $ | 91 | $ | 91 | ||||||
Increase
(decrease) in amount computed resulting from
|
||||||||||||
Resolution
and reevaluation of tax positions
|
29 | (9 | ) | 9 | ||||||||
Auction
rate securities valuation allowance
|
8 | - | - | |||||||||
Life
insurance loss (income)
|
2 | 9 | (7 | ) | ||||||||
Claim
for research and development credits
|
(9 | ) | (1 | ) | (3 | ) | ||||||
(Gain)
loss on divestitures
|
(4 | ) | (7 | ) | 1 | |||||||
Net
impact of foreign results
|
(2 | ) | 5 | (2 | ) | |||||||
Deductible
dividends under employee stock ownership plan
|
- | (1 | ) | (15 | ) | |||||||
Other
items
|
1 | (1 | ) | (16 | ) | |||||||
Income
tax expense
|
$ | 80 | $ | 86 | $ | 58 |
(In
millions)
|
||||
Balance
at October 1, 2008
|
$ | 79 | ||
Increases
related to positions taken on items from prior years
|
21 | |||
Decreases
related to positions taken on items from prior years
|
(7 | ) | ||
Increases
related to assumed Hercules positions in the current year
|
35 | |||
Increases
related to positions taken in the current year
|
29 | |||
Lapse
of statute of limitations
|
(9 | ) | ||
Settlement
of uncertain tax positions with tax authorities
|
(23 | ) | ||
Balance
at September 30, 2009
|
$ | 125 |
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
SARs
|
$ | 4 | $ | 7 | $ | 7 | ||||||
Performance
share awards
|
2 | 3 | 6 | |||||||||
Nonvested
stock awards
|
2 | 2 | 3 | |||||||||
$ | 8 | $ | 12 | $ | 16 | |||||||
Income
tax benefit
|
$ | 3 | $ | 5 | $ | 6 |
(In
millions except per share data)
|
2009
|
2008 |
2007
|
|||||||||
Weighted-average
fair value per share of SARs granted
|
$ | 2.90 | $ | 12.62 | $ | 17.67 | ||||||
Assumptions
(weighted-average)
|
||||||||||||
Risk-free
interest rate
|
2.1 | % | 3.8 | % | 4.2 | % | ||||||
Expected
dividend yield
|
2.9 | % | 2.1 | % | 1.7 | % | ||||||
Expected
volatility
|
38.5 | % | 25.8 | % | 27.3 | % | ||||||
Expected
life (in years)
|
5.0 | 5.0 | 5.0 |
2009 | 2008 | 2007 | ||||||||||||||||||||||
(In
thousands except per share data)
|
Number
of
common
shares
|
Weighted-
average
exercise
price
per
share
|
Number
of
common
shares
|
Weighted-
average
exercise
price
per
share
|
Number
of
common
shares
|
Weighted-
average
exercise
price
per
share
|
||||||||||||||||||
Outstanding
- beginning of year (a)
|
2,888 | $ | 43.92 | 2,674 | $ | 36.07 | 2,602 | $ | 41.56 | |||||||||||||||
Granted
|
1,350 | 10.49 | 434 | 53.33 | 482 | 65.78 | ||||||||||||||||||
Exercised
|
(405 | ) | 22.56 | (173 | ) | 35.37 | (829 | ) | 31.15 | |||||||||||||||
Converted
Hercules options (b)
|
939 | 31.54 | - | - | - | - | ||||||||||||||||||
Forfeitures
and expirations (b)
|
(869 | ) | 37.13 | (47 | ) | 52.51 | (36 | ) | 53.63 | |||||||||||||||
Special
dividend adjustment (c)
|
- | - | - | - | 455 | - | ||||||||||||||||||
Outstanding
- end of year (a)
|
3,903 | 33.10 |
(b)
|
2,888 | 43.92 |
(b)
|
2,674 | 41.99 |
(b)
|
|||||||||||||||
Exercisable
- end of year
|
2,294 | 42.67 | 2,234 | 39.91 | 2,064 | 36.07 | ||||||||||||||||||
(a)
|
Exercise
prices per share for SARs and options outstanding at September 30, 2009
ranged from $9.49 to $19.81 for 1,537,000 shares, $21.43 to $25.71 for
278,000 shares, from $32.28 to $38.47 for 587,000 shares, from $42.58 to
$49.79 for 654,000 shares, and from $53.33 to $65.78 for 847,000
shares. The weighted-average remaining contractual life of
outstanding SARs and stock options was 8.1 years and exercisable SARs and
stock options was 6.3 years.
|
(b)
|
As
part of the Hercules acquisition, Ashland converted certain Hercules
options into Ashland options at equivalent exercise stock price values, of
which a significant amount expired during
2009.
|
(c)
|
As
described in Note M, Ashland distributed a special $10.20 dividend to each
shareholder of record as of October 10, 2006. Adjustments were
made to outstanding grants of SARs and stock options to maintain their
intrinsic values. The number of shares was increased by a
factor of 1.18 and the exercise prices were decreased by a factor of
.85. These adjustments did not result in an increase in the
fair value of outstanding grants or any adjustment to expense
recognition.
|
2009 | 2008 | 2007 | ||||||||||||||||||||||
(In
thousands except per share data)
|
Number
of
common
shares
|
Weighted-
average
grant
date
fair
value
|
Number
of
common
shares
|
Weighted-
average
grant
date
fair
value
|
Number
of
common
shares
|
Weighted-
average
grant
date
fair
value
|
||||||||||||||||||
Nonvested
- beginning of year
|
300 | $ | 40.86 | 424 | $ | 40.28 | 453 | $ | 39.19 | |||||||||||||||
Granted
|
191 | 13.08 | 18 | 56.74 | 32 | 63.99 | ||||||||||||||||||
Vested
|
(227 | ) | 32.48 | (136 | ) | 39.34 | (56 | ) | 43.70 | |||||||||||||||
Forfeitures
|
(10 | ) | 62.06 | (6 | ) | 59.62 | (5 | ) | 55.71 | |||||||||||||||
Nonvested
- end of year
|
254 | 26.59 | 300 | 40.86 | 424 | 40.28 |
(In
thousands)
|
Performance
period
|
Target
shares
granted
|
(a) |
Weighted-
average
fair
value
per
share
|
||||||
Fiscal
Year 2009
|
October
1, 2008 - September 30, 2011
|
286 | $ | 7.99 | ||||||
Fiscal
Year 2008
|
October
1, 2007 - September 30, 2010
|
118 | $ | 50.55 | ||||||
Fiscal
Year 2007
|
October
1, 2006 - September 30, 2009
|
142 | $ | 72.52 | ||||||
(a)
|
At
the end of the performance period, the actual number of shares issued can
range from zero to 200 percent of the target shares
granted.
|
|
2009
|
2008
|
2007
|
|||||||
Risk-free
interest rate
|
0.9%
- 1.2
|
% |
3.5%
- 3.7
|
% |
4.7%
- 5.0
|
% | ||||
Expected
dividend yield
|
2.2 |
%
|
1.7 |
%
|
1.8 |
%
|
||||
Expected
life (in years)
|
3.0
|
3.0
|
3.0
|
|||||||
Expected
volatility
|
43.6 |
%
|
26.3 |
%
|
24.4 |
%
|
2009 | 2008 | 2007 | ||||||||||||||||||||||
(In
thousands except per share data)
|
Shares
|
Weighted-
average
grant
date
fair
value
|
Shares
|
Weighted-
average
grant
date
fair
value
|
Shares
|
Weighted-
average
grant
date
fair
value
|
||||||||||||||||||
Nonvested
- beginning of year
|
227 | $ | 61.87 | 119 | $ | 72.52 | - | $ | - | |||||||||||||||
Granted
|
286 | 7.99 | 118 | 50.55 | 142 | 72.52 | ||||||||||||||||||
Forfeitures
|
(21 | ) | 29.62 | (10 | ) | 54.94 | (23 | ) | 72.52 | |||||||||||||||
Nonvested
- end of year
|
492 | 31.77 | 227 | 61.87 | 119 | 72.52 |
Other
postretirement
|
||||||||||||||||
Pension
plans
|
benefit
plans
|
|||||||||||||||
(In
millions)
|
2009
|
2008
|
2009
|
2008
|
||||||||||||
Change
in benefit obligations
|
||||||||||||||||
Benefit
obligations at October 1
|
$ | 1,343 | $ | 1,562 | $ | 180 | $ | 205 | ||||||||
Assumed
obligations from Hercules
|
1,521 | - | 109 | - | ||||||||||||
Service
cost
|
38 | 36 | 5 | 5 | ||||||||||||
Interest
cost
|
204 | 93 | 20 | 12 | ||||||||||||
Participant
contributions
|
2 | 2 | 16 | 11 | ||||||||||||
Benefits
paid
|
(198 | ) | (80 | ) | (47 | ) | (31 | ) | ||||||||
Medicare
Part D Act
|
- | - | 2 | 2 | ||||||||||||
Actuarial
loss (gain)
|
675 | (267 | ) | 59 | (24 | ) | ||||||||||
Foreign
currency exchange rate changes
|
13 | (8 | ) | - | - | |||||||||||
Other
|
(5 | ) | 5 | - | - | |||||||||||
Benefit
obligations at September 30
|
$ | 3,593 | $ | 1,343 | $ | 344 | $ | 180 | ||||||||
Change
in plan assets
|
||||||||||||||||
Value
of plan assets at October 1
|
$ | 1,187 | $ | 1,505 | $ | - | $ | - | ||||||||
Assumed
plan assets from Hercules
|
1,318 | - | - | - | ||||||||||||
Actual
(loss) return on plan assets
|
381 | (261 | ) | - | - | |||||||||||
Employer
contributions
|
47 | 25 | 31 | 20 | ||||||||||||
Participant
contributions
|
2 | 2 | 16 | 11 | ||||||||||||
Benefits
paid
|
(198 | ) | (80 | ) | (47 | ) | (31 | ) | ||||||||
Foreign
currency exchange rate changes
|
13 | (7 | ) | - | - | |||||||||||
Other
|
(5 | ) | 3 | - | - | |||||||||||
Value
of plan assets at September 30
|
$ | 2,745 | $ | 1,187 | $ | - | $ | - | ||||||||
Unfunded
status of the plans
|
$ | (848 | ) | $ | (156 | ) | $ | (344 | ) | $ | (180 | ) | ||||
Amounts
recognized in the balance sheet
|
||||||||||||||||
Noncurrent
benefit assets
|
$ | 32 | $ | - | $ | - | $ | - | ||||||||
Current
benefit liabilities
|
(11 | ) | (6 | ) | (29 | ) | (14 | ) | ||||||||
Noncurrent
benefit liabilities
|
(869 | ) | (150 | ) | (315 | ) | (166 | ) | ||||||||
Net
amount recognized
|
$ | (848 | ) | $ | (156 | ) | $ | (344 | ) | $ | (180 | ) | ||||
Weighted-average
plan assumptions
|
||||||||||||||||
Discount
rate
|
5.82 | % | 7.81 | % | 5.50 | % | 7.78 | % | ||||||||
Rate
of compensation increase
|
3.67 | % | 3.73 | % | - | - |
|
Pension
|
Postretirement
|
||||||||||||||
(In
millions)
|
2009
|
2008
|
2009
|
2008
|
||||||||||||
Net
actuarial loss (gain)
|
$ | 715 | $ | 258 | $ | - | $ | (66 | ) | |||||||
Prior
service cost (credit)
|
5 | 5 | (20 | ) | (23 | ) | ||||||||||
Benefit
obligations at September 30
|
$ | 720 | $ | 263 | $ | (20 | ) | $ | (89 | ) |
2009
|
2008
|
|||||||||||||||||||||||
Non-
|
Non-
|
|||||||||||||||||||||||
Qualified
|
qualified
|
Qualified
|
qualified
|
|||||||||||||||||||||
(In
millions)
|
plans
(a)
|
plans
|
Total
|
plans
(a)
|
plans
|
Total
|
||||||||||||||||||
Projected
benefit obligation
|
$ | 3,137 | $ | 144 | $ | 3,281 | $ | 44 | $ | 75 | $ | 119 | ||||||||||||
Accumulated
benefit obligation
|
3,008 | 134 | 3,142 | 41 | 67 | 108 | ||||||||||||||||||
Fair
value of plan assets
|
2,403 | - | 2,403 | 15 | - | 15 | ||||||||||||||||||
(a)
|
Includes
qualified U.S. and non-U.S. pension
plans.
|
Actual at September 30 | ||||||||||
(In
millions)
|
Target
|
2009
|
2008 |
|
||||||
Plan
assets allocation
|
||||||||||
Equity
securities
|
55 - 75 |
%
|
11 | % | 55 |
%
|
||||
Debt
securities
|
25 - 35 |
%
|
75 | % | 29 |
%
|
||||
Other
|
5 - 15 |
%
|
14 | % | 16 |
%
|
||||
100 | 100 |
%
|
Pension
benefits
|
Other
postretirement benefits
|
|||||||||||||||||||||||
(In
millions)
|
2009
|
2008
|
2007
|
2009
|
2008
|
2007
|
||||||||||||||||||
Net
periodic benefit costs
|
||||||||||||||||||||||||
Service
cost
|
$ | 38 | $ | 36 | $ | 37 | $ | 5 | $ | 5 | $ | 4 | ||||||||||||
Interest
cost
|
204 | 93 | 87 | 20 | 12 | 11 | ||||||||||||||||||
Curtailment
|
- | - | - | - | - | 3 | ||||||||||||||||||
Special
termination benefits
|
- | - | 8 | - | - | - | ||||||||||||||||||
Expected
return on plan assets
|
(180 | ) | (113 | ) | (102 | ) | - | - | - | |||||||||||||||
Amortization
of prior service cost (credit)
|
- | - | - | (3 | ) | (3 | ) | 7 | ||||||||||||||||
Amortization
of net actuarial loss (gain)
|
15 | 5 | 17 | (5 | ) | (3 | ) | (3 | ) | |||||||||||||||
$ | 77 | $ | 21 | $ | 47 | $ | 17 | $ | 11 | $ | 22 | |||||||||||||
Weighted-average plan
assumptions (a)
|
||||||||||||||||||||||||
Discount
rate
|
7.81 | % | 6.16 | % | 5.66 | % | 7.78 | % | 5.96 | % | 5.64 | % | ||||||||||||
Rate of compensation increase | 3.73 | % | 3.74 | % | 3.74 | % | - | - | - | |||||||||||||||
Expected
long-term rate of
|
||||||||||||||||||||||||
return on plan assets | 7.97 | % | 7.62 | % | 7.58 | % | - | - | - |
(a)
|
The
plan assumptions disclosed are a blended weighted-average rate for
Ashland’s U.S. and non-U.S. plans. The U.S. pension plan
represented approximately 86% of the projected benefit obligation at
September 30, 2009. Other postretirement benefit plans consist
of U.S. and Canada, with the U.S. plan representing approximately 95% of
the accumulated postretirement benefit obligation at September 30,
2009. Non-U.S. plans use assumptions generally consistent with
those of U.S. plans.
|
|
Pension
|
Postretirement
|
||||||||||||||
(In
millions)
|
2009
|
2008
|
2009
|
2008
|
||||||||||||
Net
actuarial (gain) loss
|
$ | 472 | $ | 104 | $ | 61 | $ | (24 | ) | |||||||
Prior
service cost
|
- | 3 | - | - | ||||||||||||
Reversal
of amortization item:
|
||||||||||||||||
Net
actuarial gain (loss)
|
(15 | ) | (5 | ) | 5 | 3 | ||||||||||
Prior
service credit
|
- | - | 3 | 3 | ||||||||||||
Total
|
$ | 457 | $ | 102 | $ | 69 | $ | (18 | ) | |||||||
Total
recognized in net periodic benefit cost
|
||||||||||||||||
and
accumulated other comprehensive income
|
$ | 534 | $ | 123 | $ | 86 | $ | (7 | ) |
Other
|
||||||||
Pension
|
postretirement
|
|||||||
(In
millions)
|
benefits
|
benefits
|
||||||
Net
actuarial loss (gain)
|
$ | 46 | $ | (1 | ) | |||
Prior
service cost (credit)
|
1 | (3 | ) | |||||
Total
|
$ | 47 | $ | (4 | ) |
Other
postretirement benefits
|
||||||||||||
Pension
|
With
Medicare
|
Without
Medicare
|
||||||||||
(In
millions)
|
benefits
|
Part
D subsidy
|
Part
D subsidy
|
|||||||||
2010
|
$ | 199 | $ | 29 | $ | 33 | ||||||
2011
|
205 | 30 | 34 | |||||||||
2012
|
212 | 29 | 34 | |||||||||
2013
|
220 | 29 | 34 | |||||||||
2014
|
226 | 29 | 34 | |||||||||
2015-2019
|
1,268 | 138 | 168 |
(In
thousands)
|
2009
|
2008
|
2007
|
|||||||||
Open
claims - beginning of year
|
115 | 134 | 162 | |||||||||
New
claims filed
|
2 | 4 | 4 | |||||||||
Claims
settled
|
(1 | ) | (2 | ) | (2 | ) | ||||||
Claims
dismissed
|
(16 | ) | (21 | ) | (30 | ) | ||||||
Open
claims - end of year
|
100 | 115 | 134 |
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Asbestos
reserve - beginning of period
|
$ | 572 | $ | 610 | $ | 635 | ||||||
Reserve
adjustment
|
5 | 2 | 5 | |||||||||
Amounts
paid
|
(34 | ) | (40 | ) | (30 | ) | ||||||
Asbestos
reserve - end of period
|
$ | 543 | $ | 572 | $ | 610 |
November
13, 2008
|
||||
through
|
||||
(In
thousands)
|
September
30, 2009
|
|||
Open
claims - November 13, 2008
|
27 | |||
New
claims filed
|
1 | |||
Claims
settled
|
- | |||
Claims
dismissed
|
(7 | ) | ||
Open
claims - end of period
|
21 |
November
13, 2008
|
||||
through
|
||||
(In
millions)
|
September
30, 2009
|
|||
Asbestos
reserve - November 13, 2008
|
$ | 233 | ||
Purchase
accounting reserve adjustment
|
261 | |||
Amounts
paid
|
(10 | ) | ||
Asbestos
reserve - end of period
|
$ | 484 |
(In
millions)
|
||||
Balance
at October 1, 2008
|
$ | 149 | ||
Inherited
Hercules obligations
|
100 | |||
Disbursements,
net of cost recoveries
|
(47 | ) | ||
Revised
obligation estimates and accretion
|
18 | |||
Foreign
currency translation
|
1 | |||
Balance
at September 30, 2009
|
$ | 221 |
Revenues
from
|
Property,
plant
|
|||||||||||||||||||||||||||
external
customers
|
Net
assets
|
and
equipment - net
|
||||||||||||||||||||||||||
(In
millions)
|
2009
|
2008
|
2007
|
2009
|
2008
|
2009
|
2008
|
|||||||||||||||||||||
United
States
|
$ | 5,083 | $ | 5,549 | $ | 5,188 | $ | 609 | $ | 2,226 | $ | 1,205 | $ | 759 | ||||||||||||||
International
|
3,023 | 2,832 | 2,597 | 2,975 | 976 | 891 | 336 | |||||||||||||||||||||
$ | 8,106 | $ | 8,381 | $ | 7,785 | $ | 3,584 | $ | 3,202 | $ | 2,096 | $ | 1,095 |
Segment
Information
|
||||||||||||
Years
Ended September 30
|
|
|||||||||||
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Sales
and operating revenues
|
||||||||||||
Functional
Ingredients
|
$ | 812 | $ | - | $ | - | ||||||
Water
Technologies
|
1,652 | 893 | 818 | |||||||||
Performance
Materials
|
1,106 | 1,621 | 1,580 | |||||||||
Consumer
Markets
|
1,650 | 1,662 | 1,525 | |||||||||
Distribution
|
3,020 | 4,374 | 4,031 | |||||||||
Intersegment
sales (a)
|
||||||||||||
Functional
Ingredients
|
(10 | ) | - | - | ||||||||
Water
Technologies
|
(3 | ) | - | (2 | ) | |||||||
Performance
Materials
|
(105 | ) | (151 | ) | (154 | ) | ||||||
Consumer
Markets
|
- | (6 | ) | (1 | ) | |||||||
Distribution
|
(16 | ) | (12 | ) | (12 | ) | ||||||
$ | 8,106 | $ | 8,381 | $ | 7,785 | |||||||
Equity
income
|
||||||||||||
Functional
Ingredients
|
$ | - | $ | - | $ | - | ||||||
Water
Technologies
|
1 | 1 | 1 | |||||||||
Performance
Materials
|
6 | 16 | 10 | |||||||||
Consumer
Markets
|
8 | 5 | 4 | |||||||||
Distribution
|
- | - | - | |||||||||
Unallocated
and other
|
(1 | ) | 1 | - | ||||||||
14 | 23 | 15 | ||||||||||
Other
income
|
||||||||||||
Functional
Ingredients
|
- | - | - | |||||||||
Water
Technologies
|
1 | 2 | 3 | |||||||||
Performance
Materials
|
6 | 3 | 4 | |||||||||
Consumer
Markets
|
8 | 7 | 8 | |||||||||
Distribution
|
4 | 3 | 3 | |||||||||
Unallocated
and other
|
5 | 16 | 16 | |||||||||
24 | 31 | 34 | ||||||||||
$ | 38 | $ | 54 | $ | 49 | |||||||
Operating
income (loss)
|
||||||||||||
Functional
Ingredients
|
$ | 36 | $ | - | $ | - | ||||||
Water
Technologies
|
78 | 10 | 16 | |||||||||
Performance
Materials
|
1 | 52 | 89 | |||||||||
Consumer
Markets
|
252 | 83 | 86 | |||||||||
Distribution
|
52 | 51 | 41 | |||||||||
Unallocated
and other
|
(29 | ) | 17 | (16 | ) | |||||||
$ | 390 | $ | 213 | $ | 216 | |||||||
Assets
|
||||||||||||
Functional
Ingredients
|
$ | 2,782 | $ | - | $ | - | ||||||
Water
Technologies
|
1,919 | 495 | 514 | |||||||||
Performance
Materials
|
995 | 1,080 | 997 | |||||||||
Consumer
Markets
|
819 | 750 | 751 | |||||||||
Distribution
|
847 | 1,090 | 1,218 | |||||||||
Unallocated
and other
|
2,085 | 2,356 | 2,206 | |||||||||
$ | 9,447 | $ | 5,771 | $ | 5,686 | |||||||
(a)
|
Intersegment
sales are accounted for at prices that approximate market
value.
|
Ashland
Inc. and Consolidated Subsidiaries
|
||||||||||||
Segment
Information (continued)
|
||||||||||||
Years
Ended September 30
|
||||||||||||
(In
millions)
|
2009
|
2008
|
2007
|
|||||||||
Investment
in equity affiliates
|
||||||||||||
Functional
Ingredients
|
$ | - | $ | - | $ | - | ||||||
Water
Technologies
|
4 | 3 | 4 | |||||||||
Performance
Materials
|
54 | 59 | 49 | |||||||||
Consumer
Markets
|
18 | 15 | 14 | |||||||||
Distribution
|
- | - | - | |||||||||
Unallocated
and other
|
3 | 4 | 6 | |||||||||
$ | 79 | $ | 81 | $ | 73 | |||||||
Operating
income not affecting cash
|
||||||||||||
Depreciation
and amortization
|
||||||||||||
Functional
Ingredients (a)
|
$ | 106 | $ | - | $ | - | ||||||
Water
Technologies (a)
|
99 | 29 | 29 | |||||||||
Performance
Materials
|
63 | 46 | 39 | |||||||||
Consumer
Markets
|
36 | 35 | 34 | |||||||||
Distribution
|
28 | 28 | 25 | |||||||||
Unallocated
and other
|
7 | 7 | 6 | |||||||||
339 | 145 | 133 | ||||||||||
Other
noncash items
|
||||||||||||
Functional
Ingredients
|
33 | - | - | |||||||||
Water
Technologies
|
11 | 1 | - | |||||||||
Performance
Materials
|
4 | (4 | ) | 7 | ||||||||
Consumer
Markets
|
4 | - | 7 | |||||||||
Distribution
|
7 | 2 | 3 | |||||||||
Unallocated
and other
|
- | 27 | 19 | |||||||||
59 | 26 | 36 | ||||||||||
$ | 398 | $ | 171 | $ | 169 | |||||||
Property,
plant and equipment - net
|
||||||||||||
Functional
Ingredients
|
$ | 692 | $ | - | $ | - | ||||||
Water
Technologies (b)
|
362 | 102 | 108 | |||||||||
Performance
Materials
|
367 | 393 | 318 | |||||||||
Consumer
Markets
|
241 | 232 | 228 | |||||||||
Distribution
|
187 | 205 | 204 | |||||||||
Unallocated
and other (b)
|
247 | 163 | 109 | |||||||||
$ | 2,096 | $ | 1,095 | $ | 967 | |||||||
Additions
to property, plant and equipment
|
||||||||||||
Functional
Ingredients
|
$ | 58 | $ | - | $ | - | ||||||
Water
Technologies
|
26 | 17 | 24 | |||||||||
Performance
Materials
|
27 | 48 | 56 | |||||||||
Consumer
Markets
|
33 | 42 | 28 | |||||||||
Distribution
|
8 | 27 | 29 | |||||||||
Unallocated
and other
|
22 | 71 | 17 | |||||||||
$ | 174 | $ | 205 | $ | 154 | |||||||
(a)
|
Includes,
during 2009, amortization for purchased in-process research and
development of $5 million within both Functional Ingredients and Water
Technologies.
|
(b)
|
Fiscal
2008 and 2007 have been adjusted for the affects of the Drew Marine and
corporate aircraft assets that, during 2009, have been sold or moved to
held for sale classification within the Consolidated Balance
Sheet.
|
Quarters
ended
|
December
31
|
March
31
|
June
30
|
September
30
|
||||||||||||||||||||||||||||
(In
millions except per share data)
|
2008
|
2007
|
2009
|
2008
|
2009
|
2008
|
2009
|
(a) |
2008
|
(b) | ||||||||||||||||||||||
Sales
and operating revenues
|
$ | 1,966 | $ | 1,905 | $ | 1,990 | $ | 2,059 | $ | 2,037 | $ | 2,201 | $ | 2,113 | $ | 2,216 | ||||||||||||||||
Gross
profit as a percentage of sales
|
16.5 | % | 16.6 | % | 23.1 | % | 16.2 | % | 24.2 | % | 16.2 | % | 24.2 | % | 14.4 | % | ||||||||||||||||
Operating
(loss) income
|
(7 | ) | 46 | 112 | 52 | 152 | 87 | 133 | 28 | |||||||||||||||||||||||
(Loss)
income from continuing
|
||||||||||||||||||||||||||||||||
operations
|
(119 | ) | 38 | 48 | 72 | 51 | 66 | 98 | (1 | ) | ||||||||||||||||||||||
Net
(loss) income
|
(119 | ) | 33 | 48 | 72 | 50 | 72 | 93 | (10 | ) | ||||||||||||||||||||||
Basic
earnings per share
|
||||||||||||||||||||||||||||||||
Continuing
operations
|
$ | (1.73 | ) | $ | .61 | $ | .65 | $ | 1.14 | $ | .69 | $ | 1.04 | $ | 1.32 | $ | (.01 | ) | ||||||||||||||
Net
income (loss)
|
(1.73 | ) | .52 | .65 | 1.14 | .67 | 1.15 | 1.24 | (.15 | ) | ||||||||||||||||||||||
Diluted
earnings per share
|
||||||||||||||||||||||||||||||||
Continuing
operations
|
$ | (1.73 | ) | $ | .60 | $ | .65 | $ | 1.13 | $ | .68 | $ | 1.03 | $ | 1.30 | $ | (.01 | ) | ||||||||||||||
Net
income (loss)
|
(1.73 | ) | .52 | .65 | 1.13 | .66 | 1.13 | 1.22 | (.15 | ) | ||||||||||||||||||||||
Regular
cash dividends per share
|
$ | .075 | $ | .275 | $ | .075 | $ | .275 | $ | .075 | $ | .275 | $ | .075 | $ | .275 | ||||||||||||||||
Market
price per common share
|
||||||||||||||||||||||||||||||||
High
|
$ | 30.13 | $ | 68.99 | $ | 12.26 | $ | 49.88 | $ | 29.99 | $ | 58.58 | $ | 45.80 | $ | 48.97 | ||||||||||||||||
Low
|
8.02 | 45.79 | 5.35 | 39.82 | 10.76 | 47.01 | 23.76 | 26.81 |
(a)
|
Fourth
quarter results include a decrease in operating income of $23 million for
severance and accelerated depreciation charges associated with
cost-structure efficiency initiatives as well as a pretax gain of $56
million related to the sale of Ashland’s interest in Drew Marine, a
division within Water Technologies.
|
(b)
|
Fourth
quarter results include a decrease in operating income of $7 million for
severance costs associated with cost-structure efficiency initiatives in
Performance Materials and Water
Technologies.
|
Ashland
Inc. and Consolidated Subsidiaries
|
||||||||||||||||||||
Schedule
II - Valuation and Qualifying Accounts
|
||||||||||||||||||||
Balance
at
|
Provisions
|
Acquisition
|
Balance
|
|||||||||||||||||
beginning
|
charged
to
|
Reserves
|
and
other
|
at
end
|
||||||||||||||||
(In
millions)
|
of
year
|
earnings
|
utilized
|
changes
|
of
year
|
|||||||||||||||
Year
ended September 30, 2009
|
||||||||||||||||||||
Reserves
deducted from asset accounts
|
||||||||||||||||||||
Accounts
receivable
|
$ | 33 | $ | 29 | $ | (23 | ) | $ | (1 | ) | $ | 38 | ||||||||
Inventories
|
11 | 13 | (3 | ) | - | 21 | ||||||||||||||
Tax
valuation allowance
|
26 | 16 | - | 264 | 306 | |||||||||||||||
Year
ended September 30, 2008
|
||||||||||||||||||||
Reserves
deducted from asset accounts
|
||||||||||||||||||||
Accounts
receivable
|
$ | 41 | $ | 10 | $ | (21 | ) | $ | 3 | $ | 33 | |||||||||
Inventories
|
13 | 2 | (4 | ) | - | 11 | ||||||||||||||
Tax
valuation allowance
|
23 | 3 | - | - | 26 | |||||||||||||||
Year
ended September 30, 2007
|
||||||||||||||||||||
Reserves
deducted from asset accounts
|
||||||||||||||||||||
Accounts
receivable
|
$ | 40 | $ | 24 | $ | (15 | ) | $ | (8 | ) | $ | 41 | ||||||||
Inventories
|
16 | 2 | (4 | ) | (1 | ) | 13 | |||||||||||||
Tax
valuation allowance
|
17 | 6 | - | - | 23 |
Ashland
Inc. and Consolidated Subsidiaries
|
||||||||||||||||||||
Five-Year
Selected Financial Information
|
||||||||||||||||||||
Years
Ended September 30
|
||||||||||||||||||||
(In
millions except per share data)
|
2009
|
2008
|
2007
|
2006
|
2005
|
|||||||||||||||
Summary
of operations
|
||||||||||||||||||||
Sales
and operating revenues
|
$ | 8,106 | $ | 8,381 | $ | 7,785 | $ | 7,233 | $ | 6,731 | ||||||||||
Costs
and expenses
|
||||||||||||||||||||
Cost
of sales and operating expenses
|
6,317 | 7,056 | 6,447 | 6,030 | 5,545 | |||||||||||||||
Selling,
general and administrative expenses
|
1,341 | 1,118 | 1,126 | 1,029 | 1,034 | |||||||||||||||
Research
and development expense
|
96 | 48 | 45 | 48 | 45 | |||||||||||||||
7,754 | 8,222 | 7,618 | 7,107 | 6,624 | ||||||||||||||||
Equity
and other income
|
38 | 54 | 49 | 44 | 564 | |||||||||||||||
Operating
income
|
390 | 213 | 216 | 170 | 671 | |||||||||||||||
Net
gain (loss) on divestitures
|
59 | 20 | (3 | ) | (5 | ) | 1,284 | |||||||||||||
Loss
on early retirement of debt
|
- | - | - | - | (145 | ) | ||||||||||||||
Net
interest and other financing (expense) income
|
(205 | ) | 28 | 46 | 47 | (82 | ) | |||||||||||||
Other
expenses
|
(86 | ) | - | - | - | - | ||||||||||||||
Income
from continuing operations
|
||||||||||||||||||||
before
income taxes
|
158 | 261 | 259 | 212 | 1,728 | |||||||||||||||
Income
tax (expense) benefit
|
(80 | ) | (86 | ) | (58 | ) | (29 | ) | 230 | |||||||||||
Income
from continuing operations
|
78 | 175 | 201 | 183 | 1,958 | |||||||||||||||
(Loss)
income from discontinued operations
|
(7 | ) | (8 | ) | 29 | 224 | 46 | |||||||||||||
Net
income
|
$ | 71 | $ | 167 | $ | 230 | $ | 407 | $ | 2,004 | ||||||||||
Balance
sheet information (as of September 30)
|
||||||||||||||||||||
Current
assets
|
$ | 2,473 | $ | 3,026 | $ | 3,276 | $ | 4,250 | $ | 3,757 | ||||||||||
Current
liabilities
|
1,566 | 1,230 | 1,152 | 2,041 | 1,545 | |||||||||||||||
Working
capital
|
$ | 907 | $ | 1,796 | $ | 2,124 | $ | 2,209 | $ | 2,212 | ||||||||||
Total
assets
|
$ | 9,447 | $ | 5,771 | $ | 5,686 | $ | 6,590 | $ | 6,815 | ||||||||||
Short-term
debt
|
$ | 23 | $ | - | $ | - | $ | - | $ | - | ||||||||||
Long-term
debt (including current portion)
|
1,590 | 66 | 69 | 82 | 94 | |||||||||||||||
Stockholders’
equity
|
3,584 | 3,202 | 3,154 | 3,096 | 3,739 | |||||||||||||||
Capital
employed
|
$ | 5,197 | $ | 3,268 | $ | 3,223 | $ | 3,178 | $ | 3,833 | ||||||||||
Cash
flow information
|
||||||||||||||||||||
Cash
flows from operating activities from
|
||||||||||||||||||||
continuing
operations
|
$ | 1,027 | $ | 478 | $ | 189 | $ | 145 | $ | (76 | ) | |||||||||
Additions
to property, plant and equipment
|
174 | 205 | 154 | 175 | 180 | |||||||||||||||
Cash
dividends
|
22 | 69 | 743 | 78 | 79 | |||||||||||||||
Common
stock information
|
||||||||||||||||||||
Basic
earnings per share
|
||||||||||||||||||||
Income
from continuing operations
|
$ | 1.08 | $ | 2.78 | $ | 3.20 | $ | 2.57 | $ | 26.85 | ||||||||||
Net
income
|
0.98 | 2.65 | 3.66 | 5.73 | 27.49 | |||||||||||||||
Diluted
earnings per share
|
||||||||||||||||||||
Income
from continuing operations
|
1.07 | 2.76 | 3.15 | 2.53 | 26.23 | |||||||||||||||
Net
income
|
0.96 | 2.63 | 3.60 | 5.64 | 26.85 | |||||||||||||||
Regular
cash dividends per share
|
0.30 | 1.10 | 1.10 | 1.10 | 1.10 | |||||||||||||||
Special
cash dividend per share - Note M
|
- | - | 10.20 | - | - |